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This thesis is concerned with the measurement of the
endogenous hydrocortisone production rate by isotope dilution
in healthy human subjects and its application a) to the diagnosis
and treatment of patients with endocrine disorders and b) to the
understanding of the role of the adrenal gland in the metabolic
response to surgery, The availability of 1^C-labelled hydro¬
cortisone with highly sensitive instruments to measure its activil
and the use of chromatography and fluorimetry are the main contril
uting factors whioh render the methods used in this investigation
more reliable than the existing conventional tests for adrenal
function.
It is now well established that the adrenal cortex plays i
important role in human physiology. The hormones it secretes in1
the blood affect carbohydrate and protein metabolism; electrolyt<
and water distribution and excretion; sex functions and character
istics; appetite, strength and general well being; and the reaoi
of the body to infection, cold, trauma and shock.
But it was Thomas Addison who in 1855» first suggested tl
the adrenals were essential to health and that death occured in tl
absence when he recorded the symptoms resulting from the destructi
of the adrenal glands - a description of the disease which now be!
his name. Few were impressed by Addison's discovery at that timi
although it did prompt some experimental work in which the adrenal
of animals were removed with very equivocal results.
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The next big move came in the beginning of the 20th
Century when investigations carried out in several laboratories
indicated the probability that the adrenal cortex possessed a
hormone indispensable to life. Thus Stewart and Rogoff (1927)
were able to prolong the life span of adrenalectomised dogs by
administering to them the crude but physiologically active extract
obtained from dogs' adrenals. Likewise Hartman et al (1927) also
reported the prolongation of lives of adrenalectomised cats with
the adrenocortical principle extracted from beef adrenals.
Attempts to isolate this active principle in its pure form
and the determination of its chemical structure with a view to its
synthesis soon followed. Work in this direction revealed the
isolation not of one but several substances in the adrenocortical
extract. During the period 1936-42, nearly 30 different steroids
were isolated and since then some 10 or more have been added to the
list (Neher 1958). But it was the pioneering work especially of
Kendall, Wintersteiner and Reichstein that shed considerable light
on the chemical structure and physiological significance of this
large group of compounds isolated from the adrenal cortex.
The adrenal cortex, as is understood today, produces
steroids (androgens), 0^8 steroids (oestrogens) and C21 steroids
(corticosteroids). Most of the biologically active and inactive
steroids are C21 steroids and all of them have a highly oxidised
side chain attached to C-17. Also, most of them have an oxygen
atom at C-ll and Figure 1 shows seven of the biologically active
corticosteroids. It may also be noted that they all possess a
double bond between C-4 and C-5 atoms and an oxygen atom at C-3,
an arrangement commonly referred to as a /^-3-ketone group./
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Figure3: Anabolism of Hydrocortisone.
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group. Before the discovery of aldosterone, it was generally
believed that corticosteroids with an oxygen atom at C-ll were
concerned with carbohydrate metabolism and were referred to as
glucocorticoids, while those not oxygenated at C-ll were actively
connected with salt and water metabolism and were referred to as
mineralcorticolds. This belief no longer holds since aldosterone
has substituents at C-ll and at C-18.
Metabolism.
The fundamental building block of androgens, oestrogens
and corticosteroids is progesterone which is believed to be
derived from cholesterol. Figure 2 briefly illustrates the
biosynthesis of progesterone from cholesterol. As this thesis
will be dealing with the measurement of production rate of hydro¬
cortisone, only the anabolism and catabolism of hydrocortisone will
be briefly reviewed.
In the adrenal cortex, progesterone is converted into
hydrocortisone by successive hydroxylation at the 17, 21 and 11
positions. Figure 3 shows that the three metabolic routes, all
lead to the synthesis of hydrocortisone. It is not certain at
what stage the anterior pituitary adrenocorticotrophic hormone
(ACTH) acts in accelerating corticosteroid biosynthesis, but it is
believed at an early one, such as the conversion of cholesterol to
pregnanenolone, see Fig.2. Intravenous infusions of ACTH in normal
subjects produce a rise in blood hydrocortisone and in the urinary
excretion of hydrocortisone metabolites. The elevated concentration
of plasma hydrocortisone acts as a brake on ACTH production, thus
establishing a self adjusting system.
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The principal pathways of hydrocortisone catabolism are
shown in Figure 4. The first step involves the reduction of Ring A
and conversion of the ketone at C-3 into a hydroxyl group. This
step common to most adrenal steroids results in the production of
tetrahydro derivatives. The next point of attack is the side
chain; this gives rise to 20-hydroxylated compounds - oortol,
cortolone; P -cortol, ^-cortolone - (Fukushima et al 1955)» a^d
if the cleavage of the side chain is complete, to 11-oxygenated
17-ketosteroids. All these metabolites are conjugated in the liver
mainly with glucuronic acid and sulphuric aoid to form water soluble
products which are then excreted in the urine; only a very small
proportion of the excreted steroids or their metabolites are in
the free state.
Methods of Adrenocortical Assessment
Biological Methods.
Because derangement in adrenocortical secretions causes
various metabolic disturbances, methods for assessing adrenal
activity have attracted widespread interest. The earliest attempts
resorted to biological methods. The urine of the subject under
investigation was extracted of its cortin activity and tests were
carried out on adrenalectomised rodents. Assessment of activity
depended upon the ability of the physiological ly active steroids
present in the extract to produce certain effects on the animal.
One of the earliest was that of Seyle and Schenker (1938) who used
the ability of the urinary extracts to prolong the survival time
of adrenalectomised rats on exposure to low environmental temperature.
In 1946, Venning et al had observed that the administration of /
of adrenal cortical extracts to adrenalectomised rats resulted in
the deposition of liver glycogen in the fasting animal and these
workers adapted this as a method for estimating the activity of the
urine extract. In 1951* Speirs and Meyer described a method which
showed that the extent of fall in the circulating eosinophils in
the adrenalectomised mice on administration of the urine extract,
could be related to the amount of adrenal steroids having an oxygen
atom at C-ll present in the extract. Dorfman (1950), Simpson and
Tait (1952) described similar methods for the estimation of mineral
corticoids based on the retention of sodium and excretion of pot¬
assium in the adrenalectomised rat.
Although these biological assays provided valuable inform¬
ation regarding a particular type of response, they did not adequat¬
ely reflect the quantitative adrenocortical secretory activity.
Today, these have given way to chemical methods which are, by com¬
parison rapid and simple enough for routine clinical purposes.
17-ketosteroids (17-KS)
The determination of urinary 17-ketosteroids was the earliest
chemical method and from the clinical point of view, the most imp¬
ortant to be used in diagnosis and treatment. The main steps in
this estimation involve acid hydrolysis of the urine, extraction
with organic solvents, washing of the extract with alkali to remove
acidic material and the development of colour by application of the
Zimmerman reaction which makes use of the reaction of the active
methylene group at C-l6 with m — dinltrobenzene in strong alkali.
Urinary 17-KS arise from precursors which have been secreted
by the adrenal cortex, by the testes and possibly to some extent



















Figure5'■(a)Formationof17-Ketosteroidsn(b ,thZi m rmanReacti n.
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of adrenal origin and V3 of teetioular origin. In the female,
practically all are elaborated by the adrenal cortex. The 17-KS
of adrenal origin arise partly by the oxidative removal in the
tissues of the side ohain of certain of the Cg^ steroids and partly
from C^q steroids which have been secreted by the adrenal oortex
itself. Figure 5 illustrates the formation of 11-oxygenated 17-
ketosteroids and the Zimmerman reaction.
The total urinary 17-KS may be estimated either coibiimetrically
or polarographically but in the majority of cases the Callow-Zimm^
erman technique or some modification thereof is used. Recently
a number of microtechniques have been proposed (Drekter et al 1947»
1952; Vestergaard 1951), In these procedures, only a few milli-
litres of urine are acid hydrolysed and extracted; the final extraot
being subjected to colorimetric analysis after application of the
Zimmerman reaction.
Numerous workers have estimated the excretion of urinary
17-KS in normals and in a wide variety of clinical conditions.
Investigations have shown that the output varies with age; it is
low in young children and again declines in old age. In healthy
adult males, the range is from 10 to 20 mg per day and in healthy
adult females, from 5 to 15 mg in 24 hours. In patients with
adrenocortical hyperfunction the level is generally increased if
androgen production is affected; in patients with Addison's disease
or anterior pituitary failure affecting ACTH formation and release,
the output of 17-KS is reduced.
The 17??K3 are excreted in the urine in the conjugated form
rather than the free form. The actual nature of the conjugation




























Fiqure7: Compounds with the di hyd roxy ace tone A-Ketol side chain.
7
majority are conjugated with glucuronic acid and sulphuric acid,
figure 6. Hydrolysis of these conjugates by boiling with strong
mineral acids alone may not always be adequate from the quantitative
point of view; furthermore it has been suggested that the steroids
may form artifacts during the process of hydrolysis and extraction
and may cause either an underestimate or an overestimate of the
true 17-K8 content in urine. Thus the usefulness of 17-KS estim¬
ation as an index of adrenal function is limited to the finding
of a gross departure from the normal.
Method of Reduction.
During the last fifteen years or so, other chemical methods
which aimed at a more direct assessment of adrenal function became
available. Most of them depended on the different colour reactions
produced by the functional groups present in the 'glucocorticoid1
molecule. For analytical purposes, the all important factor is
the type of side chain at G-17. Figure 7 shows the side chain
carried by hydrocortisone, cortisone and their metabolites tetra-
hydrocortisel and tetrahydrocortisone. This is a dihydroxyacetone
side chain of which the arrangement at C-20 - C-21 constitutes an
o( -ketol grouping.
The first attempt to estimate the urinary corticosteroids
by making use of the reducing property of the o<.-ketol functional
group was made by Talbot et al (1945). The reagent used to measure
these 'reducing steroids' in urine was alkaline copper sulphate.
Likewise, a year later, Heard and Sobel using phosphomolybdic acid
reagent reported that this substitution enabled the reducing action
of the ^-ketol to be enhanced by the presence of the A^-^-ketone
group. In 1951 Chen and Tewell, reporting their experiences with/
o
with a tetrazolium salt, 2j3;5- triphenyl tetrazollura chloride,
proposed yet another analytical reagent for the measurement of
these steroids. On reduction in alkaline medium, this compound
produoes a red formazane. More recently, a similar compound but
twice as sensitive called blue tetrazolium has replaced the original.
The two original teohniaues measured only the free reducing
steroids and did not take into account the conjugated metabolites
which represented the majority fraction of steroids secreted by the
adrenal cortex. And when later it was discovered that these tech¬
niques also measured other non steroidal reducing substances in
the urine which could not be removed even with preliminary puri¬
fication thereby causing serious errors in the estimation, these
methods tended to fall into disuse. However, in recent years, a
few workers have felt it worthwhile to attempt to improve these
reducing methods and Raftopoule et al (1959) have recorded a normal
output of 7.8 - 13.2 mg/day for a molybdate method and 8.5 - 10.5
mg/day for a blue tetrazolium method - results which seem to be of
the right order when compared with the most widely accepted of present
day methods (see Table 1).
Oxidation Method.
Not long after the reduction methods had been proposed and
come into use, another method based on a different line of approach
became available. This new approach was initiated by Loweinstein
et al (1946) and later improved by Daughaday et al (1948) and by
Corcoran and Page (1948). These workers made use of the fact that
corticosteroids with a hydroxyl group on 0-21 and with or without
the same group at 0-17, react with periodic acid to yield 1 mole






























shows the mechanism of this reaction. After removal of the
excess oxidant, the formaldehyde is liberated from the reaction
mixture by steam distillation, trapped in sulphite solution and
allowed to react with ohromotropic acid. The technique was
difficult to standardise and had a number of important drawbacks.
Contaminating substances which could not be removed by preliminary
washing also yielded formaldehyde on oxidation with periodic acid.
Other urinary contaminants had a binding effect on formaldehyde
inhibiting both its full liberation and its reaction with chromo-
tropio acid. Formaldehydogenie steroids estimated after enzyme
hydrolysis have yielded figures far in excess of those obtained
by other methods. Data shown on Table 1 illustrates this point
and because of this, the method is now little used.
Table 1
Urinary corticosteroid excretion values mg/2£ hr.
Normal adult Males Females







Dunstan et al (1953)
(enzyme, formaldehyde)
7.1-62 4.9-33




Porter Silber Colour Reaction.
Another method, more important than those so far discussed,
and which employed the Porter-Silber colour reaction (1950) became
available for routine use. In this method, the urinary corti¬
costeroids are first hydrolysed with (J-glucuronidase, extracted
with chloroform or ethyl acetate and the extract purified by care¬
fully controlled wasning processes with or without subsequent chroma¬
tographic separation. The 'purified' corticosteroids with the di-
hydroxyacetone side chain in alcoholic solution are made to react
with phenylhydrazine in the presence of sulphuric acid to produce
a characteristic yellow oolour with a maximum absorption at 410 mp.
Many workers, particularly in America have closely followed the
Glenn and Nelson method (1953) in carrying out this type of estimation.
Reddy et al (1952) however, dispensed with the hydrolysis
stage and extracted the free as well as the conjugated steroids with
butanol. The butanol extract was subjected to a short step puri¬
fication and the corticosteroids with the dihydroxyacetone function
group estimated by application of the Porter-Silber colour reaction.
With proper attention to detail, published methods of
estimating Porter-Silber chromogens provide a basis of a sound and
accurate method of group analysis equal to or better than any routine
17-KS method in accuracy and reproducibility (Patterson i960).
17-Ketogenic Steroids. (17-KGS)
It is now well recognised that only a small proportion of
the hydrocortisone secreted appears as 17-ketosterolds in the urine.
The great majority are excreted as tetrahydrocortisone and tetra-
hydrocortisol. In 1952» Norymbetski proposed a method which measured
this large group of hydrocortisone metabolites to reflect adrenal /
11
adrenal function* The side chain of these metabolites were oxidised
with sodium bismuthate to generate production of 17-ketosteroids.
Estimations of the urinary 17-KS were carried out before and after
biemuthate oxidation and the difference was appropriately reported
as 17-ketogenic steroids. The main advantage of this method lies
in the fact that the oxidation of the labile side chain to the stable
17-KS group is carried out in 50$ acetic acid before the conjugates
are hydrolysed with acid.
In the opinion of Dic2falusy et al (1955) this method
developed by Norymbexafci has the following advantages: (i) The
technique circumvents the difficulties associated with hydrolysis
of 0-21 17-hydroxycorticosteroids. (ii) Normal excretion values are
higher than those reported in the case of previously published
methods. This is important in view of the fact that the reliability
criteria of the technique are probably more satisfactory than those
of previous methods. (iii) The procedure measures predominantly
steroidal material and the components identified following chroma¬
tography are the expected derivatives of known 17-ketogenic steroids,
(iv) The method is simple and is well suited for routine use in a
clinical laboratory.
Blood Studies.
It is now well established that the adrenal cortex elaborates
a large number of substances into the blood and that hydrocortisone
is the predominant steroid. Corticosterone, which is a major
steroid in some animals, is present in man in about one-tenth of the
concentration of hydrocortisone; and aldosterone, although of great
biological importance, is present in such quantities that special
isotope techniques are necessary for its determination. And soj
Ac
ao attention was paid to the measurement of plasma hydrocortisone
and like substances to correlate plasma levels with adrenocortical
activity. Some of the early methods and their results are summar¬
ized in Table 2.
The main problem particularly associated with plasma steroid
determination is that of sensitivity since even the predominant
steroid, hydrocortisone is only present in a concentration of about
10 ug$; and in addition to sensitivity there is also the problem
of specificity. Consequently many of the methods which have been
devised depend upon a preliminary separation of the steroids, often
by chromatography, followed by a suitably sensitive reaction for the
estimation.
Table 2
Early attempts to measure Plasma adrenal steroids





























Modified Silber Porter 14.0+4.5
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One of the earliest methods applicable to the routine
determination of plasma 17-hydroxycorticosteroids (17-OHCS) was
that proposed by Nelson and Samuels (1952). Their method measured
mainly hydrocortisone and depended on the presence of the dihydroxy-
acetone functional group. They extracted plasma, chromatographed
the extract on magnesium silicate and collected the third of the
three eluate fractions. The third fraction containing the 17-OHCS -
subseauently demonstrated to consist mainly of hydrocortisone by
paper chromatography - was measured by the Porter-Silber colour
reaction. With this method, normal blood levels ranged from 4 to
10 ug per 100 ml plasma. Recoveries of 1 to 4 ug of hydrocortisone
added to 10 ml of plasma and run through the florosil oolumn varied
from 55% to 116%. This method has been used in many laboratories,
particularly in the United States and when it became evident that
reproducibility in the method was not always attained, various modi¬
fications of the original technique were proposed. In 1953» Eik-
Nes, Nelson and Samuel® published additional technical details and
emphasised the importance of careful preparation of materials, parti¬
cularly the chromatographic adsorbent, Florisil.
In 1953» Bondy and Altrock published a somewhat similar
method for the analysis of 17-OHCS. It involved a complex extraction
of plasma through several steps; the final extraction being made
in a chloroform-carbon tetrachloride mixture whioh was then evaporated
to dryness and the Porter-Silber colour reaction applied. From
60 to 70$ of the hydrocortisone acetate was recovered when this steroid
was added to the plasma. Their normal mean value was 7.8+3*3 ug$.
In a more recent method, Bondy et al (1957) used paper chromatography
with fluorimetry to estimate plasma hydrocortisone. A correction /
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correction for incomplete recovery was made using 14c-labelled
hydrocortisone and a normal level of 8.1+3.6 ug$> was reported.
In the same year Morris and Williams (1953) published a
method on the polarographic estimation of steroid hormones. These
authors extracted heparinized blood with various solvents and the
extracted steroids were fractionated by partition chromatography.
The various fractions were then subjected to polarographic identi¬
fication and quantitation. Among other steroids, recovery of
added F to blood was 80$> and in normal plasma the mean concentration
of hydrocortisone was found to be 8.4 ug$. This method has not
received widespread favour because of its technical complexity.
In 1954* Sweat reported that hydrocortisone and corticost-
erone produced intense fluorescence in ethanolic-sulphuric acid
solution and that the fluorescence was measurable in a Beckman
spectrophotometer. From these studies the author made the following
generalizations: (i) the presence of a hydroxyl group at C-ll seemed
to be necessary for inoreased fluorescence and (ii) the presence of
an alpha-beta unsaturated ketone in ring A also seemed to exert an
influence on fluorescence. In 1955» Sweat published a method for
the measurement of adrenocortical steroids in peripheral blood.
Blood was extracted with chloroform and the extract was partitioned
and chromatographed on silica gel. The eluate fraction containing
hydrocortisone was then measured by sulphuric acid induced fluorescence.
The average concentration of hydrocortisone in peripheral blood was
reported as being 10.8 ug #. When A.C.T.H. was given to normal
subjects, there was a two to five fold increase in hydrocortisone
like steroids in the blood. When A.C.T.H. was given to Addisonian
patients, there was no significant increase in the level of blood
steroids as determined by fluorescence.
J-5
In 1954, Silber and Porter proposed another method for the
determination of hydrocortisone in plasma. Their method dispensed
with the need for chromatography and involved extraction of plasma
to which hydrocortisone (5ug) was added to allow for any loss of
steroid in the extraction procedure; this amount was subtracted at
the end of the analysis. An attempt was also made to diminish the
number of steps in the procedure so as to minimise the loss of steroids.
Thus the alcoholic - phenylhydrazine - sulphuric acid reagent was
added directly to the chloroform extract. The steroid passed
directly from the chloroform into the reagent and after removal of
the chloroform the amount of steroid present was estimated colori-
metrically. The average plasma level in normal subjects was 13.3
ug%. Colour reaction took place at room terapration, was complete
in about 8 hours and remained stable for another 12 hours. The
method appears to be good and readily adaptable to routine use.
Peterson et al (1957) have modified this procedure, further simpli¬
fying ill and increasing its sensitivity.
Several methods are now available for the estimation of
plasma hydrocortisone. As a rule they describe advantageous mod¬
ifications of those methods cited above. Only very recently,
working in this laboratory, Osman (1961) developed a rapid method
for the simultaneous determination of hydrocortisone and corticoster-
one starting with as lit tie as 1-3 ml of plasma. Dispensing with
paper chromatography but making use of two different sulphuric acid
concentrations, this worker measured and plotted the intensities of
the acid induced fluorescence of the plasma extract over a short
period of time. Then by making reference to the fluorescence curves
of authentic hydrocortisone and corticosterone and employment of
the proposed algebraic expression, the plasma levels of hydro-/
hydrocortisone and oorticosterone were determined.
Hydrocortisone Production Rate.
In general, hyperactivity or hypoactivity of the adrenal
cortex is reflected by increased or decreased plasma concentrations
of hydrocortisone and excretions of its metabolites. However there
may be conditions in which the output of the adrenal cortex is altei
without demonstrable changes in the corticosteroid content of blood
or urine. Thus the actual amount of hydrocortisone elaborated by
the adrenal cortex has been the subject of a great deal of speculati
and resulted in some attempts being made, see Table 3»
Knowlton in 1952» in treating 14 cases of Addisons disease
found that a replacement therapy of 12.5-25 mg of cortisone per day
was cuite adeouate, suggesting that the daily output of the normal
gland was of this order.
Several attempts have been made to correlate the excretion o
certain groups of hydrocortisone metabolites with the actual produc¬
tion rate by observing the proportion of an ingested dose which is
subsequently excreted in the form of such groups of compounds. Thu
Dorfman (1954)» from investigating eight normal male adults between
the ages of 19-35 &nd six normal female adults between the ages of
21-35, calculated the normal production rate of hydrocortisone to
be 18-21 mg/day on the basis of the quantities 11-oxy and 11-deoxy-
C-19 neutral 17-ketosteroids in the urine.
Silber (1955) administered graded doses of hydrocortisone to
4 subjects and by comparing the amount 0/ metabolite excreted after
the test dose with that excreted during: the control or basal period,
used the fraction obtained to calculate the hydrocortisone productioi
rate which indicated an average of 13.8mg/8 hrs (8.30am-4.30pm) as/
as judged from the quantity of endogenously produced phenylhydrazine
reactive chromogens in the dichloromethane extracts of glucuronidase
hydrolysable urine. V/hen the same procedure was applied to 20 malei
(21-35 years of age) and 24-hour urine collected instead of 8-hr urii
the adrenal output was calculated to be 21.9*8.2 mg/day.
Table 3
Authors Method based on
F.Prod.Rate ir
Normals mg/daj
Knowlton (1952) Replacement therapy 12.5-25
Dor^man (1954) Excretion of 11-oxy and 11-
deoxy neutral 17-KS 18-21
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In 1956 Moxhara and Nabarro, using their own modification of
the methods of Norymberski for 17-KG8 and that of Reddy et al for
17-OHCS, correlated oral hydrocortisone dosage with both ketogenic
and 17-OHCS excretion. They thereby provided data which suggested
a production of between 5.5 and 49mg/day as judged by 17-KGS and 9.5-
45mg/day as judged by the 17-OHCS.
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In 1953» Bondy and Altrock, by simultaneously collecting
samples of left renal vein and renal artery blood, determined the
difference of hormone secretion by a method of analysis of 17-OHCS.
When the difference was multiplied by the value of renal plasma flow,
the calculation revealed a production rate of 15 to 25 mg per day.
Although a method like this indioates a more direct estimate, experi¬
mentally the procedure is difficult to perform and therefore has very
limited application.
Samuels et al (1957) employing both the plasma hydrocortisone
level and the rate of disappearance of infused hydrocortisone obtained
an average production rate of 21,8 ug/KG/hr. This works out to about
36 mg/day for normals between the ages of 33-55 yrs.
The analytical procedures thus far described in the study of
hydrocortisone production rate may be hampered by incomplete enzy¬
matic hydrolysis and incomplete solvent extraction. In an attempt
to obtain a solution to these problems and to provide a more reliable
and accurate estimate of the average rate of hydrocortisone production
in man, some workers have used isotopieally labelled hydrocortisone.
In this procedure, a trace quantity of the radioactive material is
administered either orally or intravenously and the subsequent measure¬
ment of its rate of dilution with the hydrocortisone produced by the
subjects1 own adrenals is determined by comparing the specific activity
of the administered dose with that at the time of complete mixing.
Production rate of hydrocortisone is then calculated by conventional
isotope dilution expressions with analytical errors considerably
reduced since a procedure of this nature does not depend upon complete
recovery.
Peterson and Wyngaarden in 1956 and also Cape and Black (195^)/
19
used this isotope dilution technique to assess adrenocortical
function - the former from blood studies and the latter from urine
studies. In this research both these methods have been used and
the detailed procedures are described in the next chapter.
Peterson and Wyngaarden employed the gas flow type of
counter, while Cope and Black employed the end window Geiger-Muller
counter for radioactivity measurements. In this research, activity
was measured by employment of a Panax Liquid Scintillation counter
and thus the first task undertaken was the establishment of the
two methods using this new type of counter.
Using both the blood and urine methods, normal production
rate patterns were determined. Investigations were then carried
out on patients with various endocrine disorders - particularly
those with Cushing's disease and those with Hirsutism. The results
and discussion of these investigations are presented in Chapter III.
In most cases besides hydrocortisone production rate studies, other
tests of adrenal function - 17-KS, 17-KGS - were at the same time
carried out; so that in the light of the clinical picture presented,
a good comparison may be made of the various laboratory tests normally
carried out for adrenal function.
In the study of the role of the adrenal gland in the metabolic
response to surgery, the actual increase in production rate in res¬
ponse to surgical stress seemed worthwhile investigatine- together with
balance studies of sodium, potassium and nitrogen before and after
operation. Chapter IV briefly introduces this fascinating line of
research and some data concerning the hydrocortisone production and
electrolyte alterations following surgery are presented.
Chapter II i Description of Methods Used
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Method of Hydrocortisone Production Rate from
Blood Studies
The method to be described is based largely on that
described by Peterson and Wyngaarden (195&)« A dose equivalent
to 0.2 jjlc, instead of Peterson's 1 to 2 /xc, constitutes the amount
of radioactivity administered and 5 x 25 of blood are withdrawn
in the course of the experiment instead of 6 x 60 ml.
Principle.
When a small dose of labelled hydrocortisone is injected
intravenously, it promptly 'mixes' with the hydrocortisone present
in the body. If by some means it is possible to measure the degree
of dilution of the administered dose with the hydrocortisone produced
by the body, the reservoir or miscible pool of hydrocortisone in the
body may be calculated. This can actually be done by making serial
determinations of the rapidly falling specific activity of plasma
hydrocortisone at definite intervals after the administration of the
do86. The plot of the specific activities against time of withdrawal
of blood on a semilog graph reveals a straight line which extrapolated
to zero time provides the specific activity of plasma hydrocortisone
at the theoretical time of complete mixing. By comparing this specific
activity with that of the administered dose, the degree of dilution
may be calculated. Also from the graph, by consideration of the
half clearance time, the turnover may be obtained and by making use
of the conventional isotope dilution expressions, the miscible pool
and turnover rate of hydrocortisone can be calculated.
Figure 9 attempts to show at one srlance the important steps
involved in the method :
Figure 9- Main steps in the measurement of production rate from blood.
(2)
o o o o
Dose adm. at" 9-30a.m. 25ml. blood withdrawn
every '/2 hr for 2'/2 hrs.
(3)
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1. The dose is administered intravenously at 9.30 AM
2. Heparinized blood is withdrawn every £ hour for hours.
3. Plasma hydrocortisone is isolated by paper chromatography
4. The specific activities of the five eluted spots are determined
and plotted against time on a semilog graph. Extrapolation
provides the specific activity at zero time and by application
of the isotope dilution expression, the production rate of
hydrocortisone is calculated.
Reagents required :
1. Methylene chloride :
2. Benzene :
3. Methanol :
4. Sodium Hydroxide :
5. Acetic Acid :
6. Sulphuric Acid :
7. Hydrocortisone Markers :
8. Hydrocortisone Standard
9. Purified Alcohol :
BDH analar grade
N/10 approximately
80io (with diet. H20)
2mg/ml in alcohol
10 ^ s 20 jug to be used for chromatogra¬
phy
1 ug/ml in alcohol
.2ml s .2 jog to be used for fluorimetry
500 ml are treated with 40 pallets of
KOH and refluxed for 2 hours. On gentle
distillation the middle fraction is
collected.
Method.
Administration of the dose.
5.0ml of the dose solution (equivalent to 0.2 juc and of
known specific activity and ouantity of hydrocortisone) were care¬
fully pipetted into a sterile beaker and the contents withdrawn into
a syringe. The beaker was rinsed with physiological saline and /
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and the washings also withdrawn into the syringe. The dose was
administered intravenously over a period of three minutes. When
the injection was complete, blood was withdrawn into the barrel of the
syringe and again pushed back into the blood stream to ensure comp¬
leteness of administration of the dose.
Collection of Blood Specimens.
25ml of blood were withdrawn in a heparin!zed syringe every
half hour for two and a half hours after administration - the exact
time of withdrawal being noted. Plasma was separated from the red
cells as soon as possible.
Extraction.
From each specimen, 10ml of plasma were extracted with 100ml
of methylene chloride by gentle continuous rotation for 10 minutes,
then centrifuged for 10 minutes at 2000 r.p.m. The upper aqueous
layer was removed by suction and the extract was washed once with
15ml N/10 NaOH, once with 15ml ^/lO CH3COOH and once with 15ml dist¬
illed H2O; removal of the aqueous layer each time being by suction
after centrifugation. The washed extract was evaporated to dryness
under reduced pressure and in a water bath at 40°C. 10ml of dist¬
illed water treated in the same manner as plasma served as a blank
extract.
Isolation of Hydrocortisone.
Fractionation of the plasma steroids and isolation of
hydrocortisone was brought about by paper chromatography using the
Bush^f benzene/methanol water system. Each extract was redissolved
in 2 x 50 -Aib methylene chloride and transferred to the starting
line of the washed No 1 Whatman chromatography paper. The papers/
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papers were placed in the chromatography tank and allowed to
equilibrate overnight. On the next morning, benzene - saturated
with the stationary phase - was introduced and descending chroma¬
tography was allowed to proceed. At the end of a 5 to 6 hour run,
the papers were withdrawn from the tank and left to dry in the dark
for ^ hr. The spots containing the 20 jug hydrocortisone markers,
which were applied at the same time as the extracts, were located
under the ultraviolet lamp. The zones containing the extract
hydrocortisone and blank on the other limbs of the paper were cut
out at a position directly opposite those of the markers, fluted
and eluted overnight by immersion using 5 ml of ethanol.
Determination of Specific Activity.
From each eluate, 3®1 were taken for radioactivity counting
and 0.5ml (or 1ml) for sulphuric acid induced fluorimetric estimation
of hydrocortisone. The total activity expressed as counts per
minute (cpm) found in the 5®1 eluate divided by the amount of hydro¬
cortisone expressed as jug found in the same 5ml eluate provided the
specific activity of the sample.
i.e. Specific Activity » cpm in 5,ml eluate. s cpm/jug.
jugF in 5ml eluate
The specific activities of the 5 specimens thus determined were
plotted against time of withdrawal of the specimen on a semilogarith-
mic graph. The line of fit containing the points on the graph was
extrapolated to zero time to give the specific activity at the
theoretical time of complete mixing and the biological half life.
Calculation.
The miscible pool or reservoir of body hydrocortisone may






where A = the miscible pool
a = the amount of F in ug in the administered dose
Ii = the specific activity of the dose in cpm/jug
Io = the specific activity at zero time.
The rate at which the miscible pool A is replaced with newly
synthesized hydrocortisone from the adrenal cortex is obtained from
K ~ °'t|^ V°ol/hx
where K = the turnover constant and t£ » the biological
half life expressed in hours.
If A is expressed in mg., then the product of A and K provides
the turnover of hydrocortisone in mg/hr which multiplied by 24
gives the production rate in mg/day.
Example.
If the amount of hydrocortisone administered (a) was 10 jug,
the specific activity of the adm. dose (Ii) was 21000cpm/jug and
the specific activity at zero time (lo) was found to be 2l0cpm/jug
then the miscible pool :
f2100010 -1] MS(_-2IcT
= 0.99 mg
And if the biological half life t£ was found to be 60 minutes
(or lhr), then
s ; s .693 pool/hr
AK = 0.99x0.693 rag/hr
Production Rate s AKx24 « 0.99x0.693x24
- 16.3®g/day.








Measurement of Production Rate from Urine studies.
The measurement of hydrocortisone production rate from
urine is, in principle, the same as that from blood. In urine,
the main metabolite of hydrocortisone is tetrahydrocortisone, so
that to calculate the degree of dilution, it is convenient to deter¬
mine the specific activity of this metabolite and compare it with
that of the administered dose. It will be shown later that all
that is necessary to calculate the production rate from urine is
a) the measurement of the total radioactivity in the 24 hour urine
and b) the measurement of the specific activity of the urinary
tetrahydrooortisone.
Figure 10, like figure 9, attempts to show at one glance
the principle steps involved in this method:
1. Measurement of the total activity in the 24 hour urine.
2. Isolation of the urinary tetrahydrocortisone by paper chromatography
after enzymatic hydrolysis with £- glucuronidase and determination
of its specific activity.
3. Calculation of production rate by isotope dilution using data
obtained from steps 1 and 2.
This method is based largely on that described by Cope and
Black (1958); the only modification being the use of Ifowaczynski's
ethylene glycol/toluene system instead of the original Saffaroni's
propylene glycol/toluene system in the paper chromatographic separ¬
ation of the urinary steroids.
Reagents required :
1. ^-glucuronidase : (limpet)
2. Acetate Buffer : 0.5M, pH 4.6
3. Chloroform : M & B lab. Chemicals
26
4. Sodium Hydroxide : N/10 approximately
5. Toluene : B.D.H. Analar Grade
6. Ethylene Glycol : B.D.H.
7. Methanol : B.D.H. analar grade
8. Aloohol : Purified
9. Blue Tetrazolium : B.D.H.
•0r-i Tetra methylammonium hydroxide : B.D.H.
11. Hydrocortisone standard : 100/,ug/ml in ethanol
i.e. 0.2ml S 20 jug.
Method
Administration and Urine Collection.
The subject under investigation was asked to empty his
bladder first and the dose was administered either orally or
intravenously. 24 hour urine was collected without preservative.
An aliquot of urine was taken for radioactivity counting and after
correcting for quenohing by employment of an internal standard, the
total activity in the 24 hour urine was calculated and expressed as
counts per minute (cpm).
Enzymatic Hydrolysis.
Two lots of VlO total volume of urine were brought to pH 4.6
by the addition of IN N01 and stabilised with 100ml of 0.5M acetate
buffer, pH 4.6. A quantity, equivalent to 500 units per ml of urine,
of ^ -glucuronidase was dissolved in some acetate buffer solution
and added to the buffered urine. Both specimens were then incubated
for 24 hours at 37°c«
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Extraotion and Purification.
Extraction of the urinary steroids was carried out using
2x50ml chloroform for each sample and the emulsion formed during
the extraction was broken by centrifugation for 15 minutes at
2000 r.p.m. The chloroform extracts were washed twice with 15ml
N/10 NaOH to remove phenolic, acidic pigmented substances and once
with 15ml distilled water. The washed extracts were brought to
dryness under reduced pressure and on a water bath at 50°Q.
Chromatography.
The fractionation of the urinary steroids and the isolation
of the tetrahydrocortisone were brought about by paper chromato¬
graphy and the employment of the ethylene glycol/toluene solvent
system. Washed Whatman paper No.54 used. The paper was
dipped into the stationary phase solution containing ethylene glycol:
methanol (1:1) and the excess solution removed by pressing the wet
paper between two sheets of dry Whatman paper. The extracts con¬
taining the steroids were taken up with 2x.l ml chloroform and
transferred to the starting line on the paper carrying two limbs
(one for each extract). The paper was then transferred to the
chromatographic tank and as equilibration was not necessary, the
mobile phase - toluene saturated with ethylene glycol - was intro¬
duced. During the run which took 14-16 hours, the tank was kept
in the dark in a cupboard. After the run the paper was taken out
of the tank and left to dry. This is difficult and normally takes
a long time owing to the presence of ethylene glycol, but drying
may be hastened by employment of a hair dryer or by hanging the
strips in a drying cabinet operating at about 50°C.
Location and Elutlon.
To locate the tetrahydrocortisone zone, one of the limbs
on the paper was cut out and developed by dipping it into a
solution containing 1 part of 0.5$ blue tetrazolium in water and
3 parts of 10$ NaOH in 60$ aqueous methanol. In a few seconds
two distinot purplish mauve bands appeared. The one nearer the
origin was due to the water insoluble formazan formed by the inter¬
action of the tetrahydrocortisol with the blue tetrazolium and the
other which was more intense and further away from the origin was
that due to the tetrahydrocortisone. On the other limb, a section
opposite to the developed tetrahydrocortisone band was cut out,
fluted and eluted by immersion in 5ml ethanol overnight.
Specific Activity of the THE
3.0ml of the eluate were taken for radioactivity counting
and the total activity contained in the 5«0ml eluate was calculated.
To determine the concentration of tetrahydrooortisone in the 5.0®1
eluate, 0.5®1 eluate was taken and 3*2®1 ethanol were added to it.
To this, 0.1ml of .5$ BTZ in alcohol and 0.2ml of .1$ tetramethy-
lammonium hydroxide were added. At the same time, 0.2ml (*20ugF)
hydrocortisone standard was added to 3.5®1 alcohol and treated
likewise as the eluate (i.e. -+• ,1ml BTZ solution + ,2ml tetra-
methylammonium hydroxide solution). Lastly, 3*7®1 alcohol, also
treated in the same way as the unknown and standard, served as a
blank. The solutions were well mixed and kept in the dark for 90
minutes. The optical densities were read at a wavelength of 520 mp
on an SP600 against an alcohol blank. The amount of THE was cal¬
culated, multiplied by 10 and expressed as pg/5ml eluate. The /
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The specific activity of the THE was obtained by dividing the
radioactivity contained in 5ml eluate by the amount of THE in
the same eluate.
i.e. Specific Activity = ^.mA..glua5^ =
jug in the 5ml eluate jug
Calculation.
If Cu be the total count in the 24.hr urine, and SAj. the
specific activity of the administered dose, the ratio of Cu/SAj.
represents the amount of radioactive hydrocortisone present in the
urine in the form of all metabolites. And if SAU be the specific
activity of the urine metabolites, the ratio SAjp/sAu represents the
degree of dilution of the administered hydrocortisone with the hydro¬
cortisone produced endogenously, provided the administered radio¬
active hydrocortisone is metabolised in exactly the same way as the
hydrocortisone produced in the body. In practice it will not be
necessary to measure the specific activity of all the hydrocortisone
metabolites; the determination of the specific activity of tetra-
hydrocortisone (SATgE) is not only representative but also convenient.
Thus
Hydrocortisone Production Rate = Si x 3Af _ qu
oAF SA^e SATHE
Example.
If the total 24 hour urine volume is 1000ml, and the activity
contained in 0.5®1 urine is 90 cpm (corrected for quenching), then
the total activity in the 24hr urine (Ou) a l80,000cpm.
Again if the activity in the 5®1 eluate is 900 cpm and the
amount of THE in the 5ml eluate is 50 jug, then the specific activity
of THE (SAthe) s 900 = X0 cpm/^g.
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Hydrocortisone Production Rate = Cu - 180000
SAthe " 18x1000 mg
r 10mg/ day
Urinary 17-Ketogenlo Steroids.
This familiar and reliable laboratory test for adrenal
function was oarried out by a rapid micro method based on that
of Drekter et al (1952) in which eivtylene dichloride was used
as the extracting: solvent. The urinary 17-ketosteroids were
determined before and after bismuthate oxidation and the difference
provided the 17-ketogenic steroids.
(a) 17-Ketosteroids.
l6ml of urine were pipetted into a quickfit centrifug-e
tube of about capacity and to this, 6ml concentrated HC1
were added and the whole plaoed in a boiling: water bath for 10
minutes. At the end of the hydrolysis, the contents were cooled
in water and 20ml of ethylene dichloride were added. The tube
was well stoppered and shaken mechanically for 15 minutes. The
contents were then centrifuged at 2000 r.p.m. for 10 minutes and
the aqueous phase removed by suction. To remove the acidic and
phenolic substances and pigments, the ethylene dichloride extract
was shaken with 5wl distilled water for 2 minutes, then with of
3N sodium hydroxide for 5 minutes. After each washing-, the layers
were separated by centrifugation and the upper aqueous phase removed
by suotion. The washed extract was filtered through flutted No.l
filter paper into a test tube. 10ml of the filtrate were trans¬
ferred into a stoppered test tube and brought to dryness under
reduced pressure. The dry residue was dissolved in 0.2ml alcohol/
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alcohol and for colour development, the following tubes were
set up ;
1. The unknown :
0.2ml alcohol containing the urine extract
0.2ml of 2$ m-dinitrobenzene in alcohol (freshly prepared)
0.2ml of 2.5N alcoholic KOH (freshly prepared)
2. The standard J
0,2ml alcoholic solution containing O.lmg dehydroisoandrosterone
0.2ml of 2$ m-dinitrobenzene in alcohol
0.2ml of 2.5N.alcoholic KOH
3. The reagent blank :
0.2ml alcohol
0.2ml of 2$ m^dinitrobenzene in alcohol
0.2ml of 2.5N alcoholic KOH
The tubes were stoppered and placed in a bath at 25°C in the dark
for 1 hour. Then to each tube, 10ml of alcohol were added and
the contents well mixed. The optical densities were read against
an alcohol blank in an SP600 at wavelengths of 5^0 mju and 430 mp.
Readings were made at 2 wavelengths so that a correction mip-ht be
made for interfering chromogens.
Corrected reading of unknown: fading at yonu-Q.6«Readlnff at /pomp
0.73
Mg. 17-ketosteroids/24hr urine * corrected reading at S^Ornu^ •) x
Reading of standard yol.24hr
(b) Total 17-Ketosterold8.
To 4ml of urine in a stoppered test tube, 4ml of glacial
acetic acid and l.Ogm of sodium bismuthate were added and the whole
shaken mechanically for half an hour away from direct sunlight. Then
10ml of 12$> sodium metabisulphite were added and shaken to reduce /
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reduce the excess bismuthate. 6ml of concentrated HC1 were
added and the whole placed in a "boiling water bath for 10 minutes.
The contents were then cooled and extracted with 20ml of ethylene
dichloride. The extract was washed with water and alkali and
filtered into a test tube. 10ml of the filtrate were transferred
to' another test tube and evaporated to dryness under reduced pressure.
As before
mg.Total 17-KS/24.hr r Corrected reading at l520mu ^ Vol.24hr
Reading of std. * 2
mg. 17-ketogenic steroids = Total 17-KS (b) - 17-KS (a)
Radioactivity. Chromatography and Pluorlmetry etc.
as applied to the methods used.
Radioactivity.
14o is a weak (J-emitter and its measurement is therefore
limited by the low energy of the (£- particles (£ = 0.155 MeV). If
an end window or windowless gas flow counter is used which involves
plating of the source at either infinite thinness or infinite thick¬
ness and operating in the proportional or Geiger region, the sensi¬
tivity is low and there are the wellknown difficulties in obtaining
reproducible plating of the material to be assayed. Correction
has to be made for self-absorption by reference to a pre-calibrated
self absorption curve.
The assay of in the gas phase after combustion of the
biological material overcomes the difficulty of plating the samples
and low sensitivity associated with end window counters. Counting
efficiency is almost 100# due to the elimination of self absorption
losses but the technique is laborious and reouires considerable
skill in operation. As an ordinary clinical laboratory tool,
however, the disadvantages are too great.
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The liquid scintillation counting of *^<3, in which the
radioactive material is incorporated into a liquid phosphor and
the scintillations "observed" by means of a photomultiplier, is
gaining increasing popularity because of its high sensitivity,
good reproducibility and the elimination of the window absorption,
the necessity for plating and the elaborate technique required for
gas counting.
Developments of liquid-scintillation counting as a practical
method for the assay of radioisotopes in biological samples followed
the work of Reynolds, Harrison & Salvini (1950) and Kallman & Furst
(1950), Reviews of progress and development in liquid scintillation
counting have been given by Davidson and Fiegelson (1957) and Bell
and Hayes (1958). Guinn (1958) and Stitch (1959) have reviewed
the advantages and disadvantages of liquid scintillation counting.
The advantages cited include all those which have already been
mentioned and amongst the disadvantages are the high cost of the
complex apparatus, the lowering of the efficiency caused by quenching
and the limitation of its use to samples soluble in the liquid phosphor
In this research all counting of *4o was carried out with a Liquid
Scintillation Counter,
Apparatus.
The assembly (Type SC/LP, Panax Equipment Ltd.) for
scintillation counting of *4c consisted of a lead castle, amplifier
(Type 425G) with a gain of x 1000 and an automatic counter (Type
AC 300/6). Tap water was passed continually through the cooling
coils of the head unit. The activity of solutions were measured
in pyrex containers fitted with caps and with a capacity to hold a
maximum of 15ml of solution. Optical contact between the window j
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window of the counting vessel and the photomultipller tube was
maintained by the use of silicone oil (MS200/20).
Radiochemicals.
4-14c hydrocortisone of specific activity 21.7uc/mg was
obtained free from the National Institutes of Health; Bethesda,
Maryland, U.S.A. This material arrived in sealed ampoules each
containing 5juc and in a solution of 95# benzene and 5# methanol.
Organic Scintillators.
The choice of a suitable phosphor is very much a matter of
personal choice. The author preferred the use of TTP/4 organic
scintillator based on Toluene simply because it was cheaper and
kept well.
Optimum working Conditions.
As this equipment was being used for the first time, it
became necessary to determine the optimum working conditions for
the counting of 14c isotopes. In particular the extra high tension
(EHT) and discriminator bias voltages which gave the greatest effic¬
iency had to be determined. Thi9 was carried out by recording the
background and count rate of a 14c-source at each of a number of EHT
settings (900-l600v) against a few bias discriminator voltages (5-20v).
Figure 11 shows 5 source ^/background (S^/B) curves from which working
voltap-es of 1200v and 12v were selected for the EHT and discriminator
bias respectively for the counting of 14c.
Preparation of the Dose,
The ampoule was carefully cut with a file and the contents
equivalent to 5/^ were transferred by meane of a clean syringe into /
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into a Quickfit (B24,50ml) test tube. The ampoule was rinsed
twice with 1ml methanol and the washings added to the test tube
containing the radioactive material. The pooled solution was
evaporated to dryness under reduced pressure using the water pump
and bath at 40°C. The dried extract was redissolved in 5ml alcohol
and this solution represented the stock solution. One ml. of this
stock solution, equivalent to about ljuc was diluted with 19mlj of
sterile distilled water so that 4 to 5®1 of this 5$ ethanolic solution
containing 0.2juc served as one dose. To evaluate the specific activ¬
ity of this dose solution, 0.2ml were taken for radioactivity counting
and the same amount for fluorimetric quantitation of hydrocortisone
content. So that if 5ml of this solution were administered, its
total activity, specific activity and amount of hydrocortisone present
had all been pre determined.
Counting Procedure.
In all counting procedures, 5ml of the toluene phosphor were
always blended with 4ml of alcohol. The active solutions were
brought to the same temperature as that in the castle by standing
the glass containers holding them on running tap water and in the dark.
When the sample was housed in the castle, a further 8-10 minutes were
allowed for dark adaption before counting commenced. The proportion
for the various types of samples for counting were as follows J
Toluene Phosphor Aloohol Active Sample
ml.* ml. ml.
Background 5 + 4 +





The background was counted until 4000 counts were recorded and the
active samples until 10000 counts or a counting period of 1 hour -
whichever was the faster. The dose solution and eluates containing
the urinary tetrahydrocortisone were very active samples and 10000
count8 were recorded in a few minutes; but the eluates containing
the plasma hydrocortisone contained relatively much smaller amounts
of radioactivity which decreased progressively from the 1st specimen
to the 5*h specimen and consequently required a much longer time
to count.
With all liculd scintillation counting, quenching tends to
lower the counting efficiency. Several investigators have studied
the effect on counting efficiency of organic solvents commonly used
in biochemical investigations, (Guinn 1958; Stitch 1959; Brown and
Bradman 1961). Diethyl ether and ethanol have been reported to
have only a slight auenching effect; but acetone and chloroform
depress the efficiency considerably. Aqueous solutions, particu¬
larly urine - because of the pigments and dissolved salts - may
sometimes exert a considerable quenching effect. To correct for
quenching when counting urine an internal standard of known count
rate was used. Counting of the urine was carried out before and
after the addition of the standard; the observed count rate of the
standard in urine was compared with its true value and so a correction
factor to correct for quenching could be obtained.





















If the urine sample (minus background) registered 90cpm and
the urine+ standard registered 170cpm, then the observed count rate
of the standard was (170-90)cpm. If the true count rate of the
standard (.2ml) registered, say, 100 cpm, then the corrected count
rate of the urine sample was
90 x 100 = 1150pm
170-90
Urine does not mix with toluene but blending the phosphor with 4»1
of alcohol, up to 0.5ml urine may be incorporated. Good mixing is
ensured by erentle swirling for about 10 seconds.
Counting Efficiency.
With the exception of the eluates containing the plasma
hydrocortisone, all counting carried out gave an accuraoy with a
standard error of 31° or less. The counting of the radioactively
weak plasma samples gave an efficiency with standard errors ranging
from 4# for the first sample to 10ft for the last sample. The count
rate of the background had always been about 60 c.p.m.; that of the
tetrahydrocortisone eluate, more than 600 cpm and those of the plasma
eluates from 5© cpm for the first to about 10 cpm for the last. It
may be argued that the count rates of the plasma samples in relation
to the background are questionable. An experiment was carried out
to test the validity of this argument and the results are recorded /
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recorded on Table 4. 4ml of a standard solution having a fairly
high count rate were counted. Subsequently aliquots of 2ml, lml,
0.5ml, 0.3ml, 0.2ml, 0.1ml were counted and the observed count rates
were compared with the theoretically true count rates (based on the
count rate of the first sample)* The data obtained suggested that
a signal count rate of at least 10 cpm may still be fairly accurately
counted.
Counting Efficiency of Small count rate
Table 4
Std.Solution ml. Observed c.p.ra. Theoretical c.p.m. % Efficiency
4 488 (488) -
2 237 244 97
1 124 122 102
0.5 60 61 98
0.3 37 36 103
0.2 24 24 100
0.1 14 12 117
Washing and Disposal.
Particularly when low count rates are encountered, all glass¬
ware have to be scrupulously clean. This degree of cleanliness was
achieved by washing all test tubes, flasks, bottles etc. with teepol
using a brush, copious amounts of tap water and finally rinsing the
glassware with distilled water. Pipettes were cleaned by dipping
them into containers containing (a) solution of teepol (b) tap water
(c) distilled water (d) acetone and flushed by suction. Disposal
of radioactive 'waste' did not present a problem since -^c is a /
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a very weak ^-emitter and the amount normally used was very small.
An assurance had heen obtained from the Medical Physics department
of Edinburgh that washing the radioactive waste down the sink with
plenty of water was quite safe from the point of view of public health.
Chromatography.
A large number of steroids present in blood and urine can
effectively be separated into groups or individual components by
chromatographic techniques. Several different chromatographic
solvent systems are available for use with adrenocortical steroids
and the choice must depend upon the specific requirements of the
problem under study. Generally speaking, fractionation of the
steroids are brought about by adsorption chromatography or/and
partition chromatography.
In adsorption chromatography, a mixture of steroids in
solution is passed through a finely divided adsorbent. The various
steroids are adsorbed at different distances alonr the length of
the column and may be separated either by cutting the column and
dissolving each steroid in a suitable solvent or by passing a solvent
through so that the various steroids pass out of the bottom of the
column in an order which is dependent upon their physical properties
and the adsorption of the column.
In partition chromatography, the column is impregnated with
one solvent (the stationary phase) and the mixture of steroids diss¬
olved in a second solvent (the mobile phase) passed through it. The
steroids are separated in an order depending, not upon the adsorption,
but upon their relative solubilities in the two solvents. This
principle is applied in paper chromatography where filter paper is
used as the support for the stationary phase when non volatile /
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non volatile solvents are used; or the filter paper is allowed to
become saturated with respect to the two solvents when volatile
solvents are used. Paper chromatography has some advantages over
column methods - several samples may be analysed at the same time.
Two paper chromatographic procedures had been used in the
measurement of hydrocortisone production rate. When blood was the
starting material, isolation of plasma hydrocortisone was the factor
which determined the use of the Bush^ (1952) solvent system. Volatile
solvents were used in this partition system which was composed of
aqueous methanol as the stationary phase and benzene saturated with
methanol as the mobile phase. When urine was the starting material,
isolation of tetrahydrocortisone the main metabolite of hydrocortisone,
was the main factor which determined the use of the Zaffaroni (1953)
solvent system subsequently modified by Rjwacaynski and Koiw (1957)»
in that ethylene glycol/toluene as the partition system was substituted
for Zaffaroni's original propylene glycol/toluene system. This mod¬
ification resulted in cutting down the running time from 36 hours to
16 hours without loss of sharpness of separation.
Paper.
With the Bush^ system Whatman No.l paper was used and with
the Zaffaroni system, Whatman No.54. In both oases, the paper was
cleaned by exhaustive capillary washing continuously for 3 days with
95^ methanol to reduce the 'blank*. Also in both cases, descending
chromatography was carried out in the dark and at room temperature.
The paper was cut into strips, 45cm long and 14cm wide and further
subdivided to give five 2cm limbs for use with the benzene-methanol-
water system and two 4°m limbs with the ethylene glycol/toluene system.
The starting line was ruled 12cm from the upper edge and the limbs /
limbs were joined at the top and the bottom to prevent tangling and
cross contamination during handling.
"Spotting-on" Support.
It is often difficult to find a convenient support for the
paper when applying the spots of material on to it. The apparatus
used and to be described here kept the chromatography paper clean
and also held it in such a way that a drying current of air could
be continuously applied from above or below. It consisted of two
rectangular plates 50cm x 28cm in plywood joined at one edge by
adhesive plaster so that both plates could be opened or closed like
the covers of a book. A sector 20cm x 3cm was cut out of each plate
in the same position so that the paper to be spotted on was sandwiched
between the plates and only that part of the paper to be applied was
exposed. At the time of application, the plates were placed on a
support at one end with that part to be applied slightly in a raised
position. This arrangement not only facilitated operation but also
allowed the drying current of air from a hair dryer to be channeled
upwards directly on to the point of application thus limiting the
diameter of the spot to a minimum.
In both procedures, rectangular Shandon all glass chromato¬
graphic tanks, 57cm x 30cm x 20cm were used. The tanks were lined
on all sides by paper always kept wet with the mobile solvent present
at the bottom of the tank to a depth of about . In the Bush^ tank,
a 500 cc beaker, also lined with paper but containing the stationary
solvent was placed on the floor of the tank - this solution was
changed every fortnight. The covers of both tanks were cushioned
with foam rubber and soft transparent plastic sheets. This arrange¬
ment enabled the covers, by means of rubber bands, to sit more /
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more tightly on the tanks, thus efficiently keeping the atmosphere
in the tank saturated with the vapours of the solvents. In the
modified Zaffaroni system where the paper had first to he impregnated
with the stationery phase, ethylene glycol/methanol (1:1), equili¬
bration was not necessary. With the Bush^, equilibration was allowed
to proceed overnight (for convenience). The mobile phase was intro¬
duced through a stoppered hole in the middle of the cover and lead
directly into the trough.
Location,. Elution and Quantitation.
To locate the position of the plasma hydrocortisone spots,
the dried paper was held against an ultraviolet lamp and the positions
of the hydrocortisone markers, recognised as opaque spots, were marked
out. Zones on th« other limbs, direotly opposite these markers were
out out. Very rarely did the amount of hydrocortisone present in
10ml plasma show up as spots to the naked eye. The position of the
urinary tetrahydrocortisone was determined by developing one of the
limbs with blue tetrazolium solution made up of 1 part of 0.5% BTZ
in water and 3 parts of 10% NaOH in 60% aqueous methanol. As ment¬
ioned earlier, two distinot mauve bands appeared within a few seconds;
the one nearer the origin waB due to tetrahydrocortisol and the broader
one further away from the origin was due to tetrahydrocortisone. A
zone opposite to this broader band was cut out from the other limb
and in all cases elution of the steroids were carried out by flutting
the cut paper and immersing in ethanol overnight.
Quantitation of the tetrahydrocortisone was carried out by
reaction with "blue tetrazolium made alkaline with tetramethylammonium
hydroxide. Maximum colour development was allowed to proceed at
room temperature, in the dark and at the end of 90 minutes the /
O.D.
Minutes CStanding in dark)
Figure 12: Development and stability of colour VS Time.
O.D.
Wavelength mp.
Figure 13: BTZ reaction absorption spectra.
the optical density was read at a wavelength of 520 mu. Fisrure 12
shows a plot of colour development against time, indicating that
standing in the dark at room temperature for 90 minutes was sufficient
and Figure 13, shows a plot of optical density versus wavelength
indicating an absorption maximum at 520 mju for authentic and eluted
tetrahydrocortisone.
The quantitation of plasma hydrocortisone was carried out
by fluorimetry and this will now be discussed.
Fluorescence of Steroids.
It has been known for many years that various steroids when
treated with certain concentrated or anhydrous acids, fluoresce
brightly under suitable illumination. Wieland, Btraub and Dorfmuller
(1929) found that oestrogenie hormones developed a yellowish orange
colour and a bright green fluorescence when dissolved in a mixture
of concentrated sulphuric acid and acetic anhydride. In 193&>
Wintersteiner and Pfiffer reported a similar fluorescence when cortisone
and hydrocortisone were treated with concentrated sulphuric acid.
In 1951» interest in this phenomenon was revived by the finding of
Neher and Wettstein that all the plisiollogically active steroids when
isolated by paper chromatography fluoresced with distinctive colours
under ultraviolet illumination and when heated with phosphoric or
sulphuric acid or acetic anhydride. In 1952» Finkelstein developed
a quantitative fluorophotometric assay for certain corticosteroids
dissolved in 85$ phosphoric acid and with the aid of heat. In 1954,
Sweat reported a more sensitive method in which the steroids were
dissolved in concentrated sulphuric acid at room temperature. In
this research, this method described by Sweat was largely employed.
It was simple and very sensitive. With suitable fluorometers, a /
^Transmission Figure14:Relationshipbetweenfluoresc nceandconcentration ofHydr cortisone.
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a quantity as little as 0.05M£ of hydrocortisone may still be
measured.
Apparatus.
The Aminco-Bowman Spectrophotofluorometer was used. The
assembly consisted of a Xenon Lamp Ballast and Control, an optical
unit, a photomultiplier, a cathode-ray oscillograph and a recording
drum. Light from the Xenon lamp is dispersed by the activating
monochramator (grating type) and the monoctaomatic radiation falls
on the sample. A similar mcnochromator disperses the fluorescent
light from the sample into a monochromatic radiation and this falls
on a photomultiplier tube. The light is transformed into a weak
electrical signal and fed into a photometer which is amplified.
The photometric output may be recorded from the tracings on the
recording drum or from a scaler unit in terms of percentage trans¬
mission or optical density.
Experimental.
0.5ml (or 1ml) of the eluate was evaporated to dryness and
the residue redissolved in 0.2ml alcohol. 1.8ml of 80$ HgSO^ were
rapidly added to it - the contents being well mixed - and left to
stand in the dark at room temperature for 40 minutes. The acid
mixture was then transferred to a fused quartz cell and the fluor¬
escence measured in the fluorometer operating at an activating
of 48O mu and a fluorescent of 540 mju. A standard of O.lpg or
0.2^ig of hydrocortisone treated likewise was read with the unknown
sample. The hydrocortisone standard was read against an alcohol
blank and the plasma hydrocortisone samples against paper blanks -
the blanks being similarly treated as the standard or plasma hydro¬
cortisone.
Fluorescence
Figure 15(a): Activating Spectrum of Hydrocortisone.
Fluorescence
A
3OO 400 500 bOO 700
Figure 15(b): Fluorescent Spectrum of Hydrocortisone.
800nyJ-
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A linear relationship was found to exist between the
intensity of fluorescence and the concentration of hydrocortisone
over a wide range and Figure 14 shows this relationship from O.lpg
to 0.4)ig hydrocortisone - a range which corresponds to 10>ig^ to 40pg$
of hydrocortisone in plasma. Figures 15a, and b, show the activatin
and fluorescent spectra of authentic 0.2pg hydrocortisone. A maximu
activating absorption was obtained at 480 mp and a maximum fluorescen
absorption at 540 mp.
Fluorescence takes time to develop and Figure 16 shows the
relationship of development and stability of fluorescenoe with
respect to time. The graph shows that maximum fluorescence devel¬
oped about 20 minutes after the addition of the acid to the alcoholic
steroid solution. The fluorescence remained steady for at least
2 hours after which the intensity of fluorescence diminished pro¬
gressively.
The value of the fluorometric method of measurement of
hydrocortisone and of other steroids lies in its simplicity and
marked sensitivity. Although claims have been made that acid
induced fluorescence of certain steroids are specific reactions,
it is generally agreed from the results of many studies, that the
chromogenic and fluorogenic properties of steroids treated with
concentrated acids result from very complex and relatively unspecific
reactions. The course of these reactions can be profoundly influ¬
enced by relatively small changes in time and temperature of reaction
exposure to light, amount of trace contaminants and other reaction
conditions. Fortunately too because of this, a wide variety of
reaction procpedures can be selected, each of which favours a apecifi





























It is of interest to point out once a«rain, that the great
advantage of using radioactive isotopes in the measurement of hydro¬
cortisone production rate is the overcoming of the problems of losses
due to hydrolysis, extraction, washing, transfer to paper etc. In
the two methods previously described the calculated production rates
by isotope dilution depended upon the evaluation of the specific
activities (either of hydrocortisone or of tetrahydrocortisone) and
these were not affected by incomplete recoveries. Still, it was
felt desirable to assess such losses - as there were bound to be -
particularly in connection with the measurement of plasma hydro¬
cortisone levels.
In a series of eight plasma samples withdrawn at 9.30 A.M.
from patients with no apparent endocrine abnormalities, 10ml of the
plasma in each case were subjected to the whole process of extraction,
washing, chromatographic isolation, elution and fluorometric deter¬
mination. The observed (uncorrected for losses) levels of plasma
hydrocortisone are shown on Table 5« A normal ranre of 4.0 - 8.8 up#
and mean of 6.6 ± 1.5ug# were obtained.
When known amounts of authentic hydrocortisone were added
to the plasma, the percentage recoveries obtained are presented on
Table 6. A range of 52 - 65# of the added hydrocortisone was re¬
moved with a mean recovery of 59 A 4#. Although there appeared to
be good reproducibility in the method used, the loss due to the
various steps was considerable.
H-f
Table 5 Eight Normal Plasma Levels of F
Case Level
No. 1 4.0 ug# in duplicate (mean)
2 5.6 » it
3 7.4 " ii
4 8.8 « single determination
5 4.7 " it
6 6.9 M n
7 6.7 " n
8 8.2 « in duplicate
MEAN 6.6 ± 1.5ug#
Table 6 % recovery of added F to Plasma
j
Added to 10 ml Plasma Recovery;
1 ug 55 $
1 ug 55 M
1 ug 53 "
2 « 52 »
2 » 65 "
2 » 63 H
3 " 55 M
3 " 60 "
MEAN 57 ± 4 $
.
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The next experiment was designed to find out if this loss
could be due to that stage of the analysis which involved transfer
of the extract on to the paper and to chromatography, elution and
fluorimetric estimation. Accordingly, aliquots of standard hydro¬
cortisone corresponding to 1, 2, and 3 ug were pipetted into glass
stoppered test tubes and evaporated to dryness. The residues were
redissolved in small quantities of methylene chloride and transferred
to Whatman paper, chromatographed, eluted and subjected to fluori¬
metric estimation. The results of this experiment are recorded on
Table 7» A mean recovery of 99 ± 9^ was obtained implying that
virtually no loss was due to this stage of the analysis and that
the loss reported earlier must have come from the extraction and
washing stages.
Table 7 ^ Recovery from Paper Chromatography.
Applied to Paper & Recovery
1 ug 117, 104, 112, 97 (in quadruplicate)
2 « 92, 92, 85, 92 "
3 " 101, 103, 96, 94
MEAH 99 ± 9 #
To test this implication, known amounts of radioactive
hydrocortisone were added to plasma and the plasma extracted with
100 ml methylene chloride. The extracts were washed once with 15 ml
*/l0 NaOH, once with 15 ml N/l0 CH3COOH and once with 15 ml distilled
H2O. They were then evaporated to dryness and the residues, rediss¬
olved in ethanol were counted for recovered radioactivity. The
results of this experiment are recorded on Table 8.
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Table 8 #> Recovery from Extraction and washing




















MEAN 63 ± 3 $
From the four dererminations, a recovery of 63 £ 3$ was
obtained. This conclusively indicated that the overall loss of
about 40$ was due mainly to the extraction and washing stages.
The urine method, as was mentioned earlier, depended upon
the measurement of the total count (Ou) and the specific activity
of the isolated tetrahydrocortisone (SA^he). The measurement of
this latter presented no problem but that of the former did, since
the incorporation of 0.5 ml urine into the liquid phosphor produced
a slight turbidity and this would tend to depress the true count rate
of radioactivity present. Correction for this quenching wa® brought
about by the employment of an internal standard of known count rate
which was of the same order as the activity found in the urine. To
test the validity of this operation, 4 different 0.3 ml urine samples
were used. To each, a quantity of radioactivity equivalent to 103
c.p.m. and an internal standard were added. Observations were made
before and after the addition of the internal standard and the results
are presented on Table 9.
Table 9 Validity for Correcting for Quenching.
Urine Sample Added Observed Corrected
s
$ Accuracy.
1 103 c p.m. 71 c.p.m. 104 c.p.m 101 $
2 103 it 90 11 98 11 95 "
3 103 11 89 11 106 11 103 H
4 103 11 94 11 104 11 101 "
MEAN 100 ± 3$
The results show that the employment of an internal standard to
correct for quenching effects was essential and the method used
was quite reliable.
In summary it may be concluded from the foregoing obser¬
vations that a) the levels of plasma hydrocortisone in 'normal1
individuals, as estimated by the blood method described, range
from 4.0 - 8.8 ug $ with a mean of 6.6 ± 1.5 ug $, and that these
uncorrected values represent about 60$ of the true value; the loss
of the remaining 40$ being mainly due to the extraction and washing
stages in the method. b) Correction for quenching due to urine
is essential and valid since the method employed recorded an accura<
of 100 ± 3 $,
Chapter III : Results and Discussion
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Results.
When the methods to be used became established, it seemed
desirable first of all to investigate the normal production rate
patterns (using both the urine and blood methods) before actually
applying them to the investigation of disease states. Accordingly,
from a series of seven healthy young adults between the ages of 22
and 31 years, a normal range was obtained. Each was given a dose
containing about 0.1 /ic to drink and 24 hour urine was collected.
The results of this first investigation are summarised on Table 10.
















G.d.W, 31 U 130000 114060 88 10.1 11.4
A.d.W. 24 F 130000 123200 95 14.0 CO.CO
M.S. 26 M 130000 101800 83 9.1 12.0
T.I. 24 M 130000 108000 83 5.7 18.9
H.M. 28 M 130000 100940 78 8.5 11.8
J.B. 26 M 130000 110960 85 7.5 14.7
I.W. 22 M 130000 107200 82 6.2 17.3
83 ± 5 13.3 ± 3
A normal range of 8.8 - 18.9 mg/24hr with a mean of 13*3 £ 3 mg/24hr
was obtained. This compared well with Cope and Black's normal range
of 5 - 24 mg/24hr with a mean of 11.8 ± 2.25 mg/24hr which was obtained
from investigating a series of eight convalescent subjects, presum¬
ably from a wider age group. The results also showed that excretion
of the administered dose was almost complete in 24 hours and thQ^HI^v
amount ranged between 78 &nd 95$ with a mean of 83 ± 5$• Date /
Data have also been obtained in the course of one special investi¬
gation which suggested that during the first 8 hours following the
administration of the radioactive material, 50$ of the dose was
excreted into the urine. During the subsequent 8 hours some 20ft
and during the last 8 hours another 10$ giving a total urinary
excretion of about 80$ in 24 hours.
A study of the distribution of the urinary seemed worth¬
while investigating; for example it would be of interest to know
what fraction of the administered dose appeared in the urine as
free unconjugated steroids, or as £-glucuronidase hydrolysable
steroids or as tetrahydrocortisol (THF) and as tetrahydrocortisone
(THE). In order to evaluate these fractions, one aliquot of
urine was acidified to pHl and extracted with an eoual volume of
chloroform. The extract was then washed with 10ml 10 NaOH, with
10ml distilled water and evaporated to dryness. The residue was
redissolved in alcohol and its activity measured. This fraction
was taken to represent the iree unconjugated urinary steroids and
the activity obtained was expressed as a percentage of the dose
administered. A second 50®! aliquot was brought to pH 4.6 and
subjected to p -glucuronidase hydrolysis at 37° for 24 hours. After
which, the urine was extracted with chloroform, washed and dried.
The extract was redissolved in alcohol and counted for radioactivity.
This fraction was taken to represent the conjugated, £ -glucuronidase
hydrolysable steroids. A third aliquot was brought to pH 4.6,
subjected to enzymatic hydrolysis, extracted and chromatographed.
The tetrahydrocortisol and tetrahydrocortisone zones were located,
cut and eluted overnight. The activities of these two zones were
then counted and from a series of 4 cases investigated, the results
are presented on Table 11.
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T.l. 130000 83 0.98 21 1.0 5 :
H.M. 130000 78 0.42 18 1.1 7
J.B. 130000 85 0.97 16 1.3 4
IiW.
__
130000 82 0.62 24 1.3 7
The results obtained suggested that less than 1$ of the administered
dose existed in the urine as free unconjugated steroids; between
16 and 2ti$ as £-glucuronidase hydrolysable steroids; between 1
and 1*3$> isolated tetrahydrocortisol and between 4 and 7$ as
tetrahydroc->rtisone. From consideration of the total amount ex¬
creted in the urine and the amount in these various fractions, it
will be noted that a large percentage is 'hydrophilic* and not
extractable by chloroform.
As an extension to the above studies, the quantitation of
tetrahydrocortisol and tetrahydrocortisone together with the measure¬
ment of their specific activities had also been carried out and the
results are summarised on Table 12. The results obtained suggested
a normal excretion of 297-560 jag/24 hr. for tetrahydrocortisol and
941-2832 jag/24hr for tetrahydrocortieone. There also appeared to
be a good correlation between the specific activities of the THF and
THE fractions suggesting that the administered radioactive hydro¬
cortisone had been treated by the body as if it were the endogenously
produced hydrocortisone. It therefore entered in the same /
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same proportion into all the matabolites imparting to them the
same specific activity.






Ug/24hr. SP. Activity pg/24hr. SP. Activity
T.l. 578 5.0 2177 5.8
H.M. 297 8.0 940 8.5
J.B. 397 8.5 1655 7.5
I.I. 560 5.8 2832 6.2
McC. 552 1.9 2016 2.2
_!
When it is considered that to measure the hydrocortisone
production rate from blood studies, the dose has to be injected
and 25ml of blood have to be withdrawn every \ hour for hours,
it is not surprising that healthy ♦normal1 volunteers were very
difficult to find. It was therefore suggested that convalescent
subjects or patients with no apparent endocrine abnormality misrht
be the next best thing to investigate and to use them as normals.
Accordingly 3 convalescent subjects and 2 pre-surgical patients
were subjected to the test and the results are summarised on Table 13.
The results obtained suggested that the normal hydrocortisone
production rate, as measured from blood studies, ranged from 16.1 to
30.2 mg/day. Other information obtained indioated that the size
of the miscible pool ranged from O.87 mg to 3*1 mg; the biological
half life from about 60 minutes to 120 minutes and a rate of replace¬
ment or turnover rate of 0.34 to 0.86 pool/hour. All these results
agreed well with those obtained by Peterson and Wyngaarden, the /
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J.T. 35 M 9.6 21750 120 0.95 1.73 0.73 1.26 30.2
G.E. 66 M 9.0 21950 64 1.90 3.10 0.39 1.11 26.6
w. 30 M 9.6 21750 130 1.65 1.60 0.42 O.67 16.1
A.W. 60 M 11.32 22497 290 O.83 O.87 0.86 0.75 18.0
H.C. 41 F 9.6 21750 215 0.98 0.96 0.71 0.68 16.3
A - miscible pool = a - lj
where a = amount ouf F in the dose
Ii = specific activity of dose
I0 = specific activity at zero time
K - rate of replacement or turnover - 0.691
tT"
where t^ - half life expressed in hours
KA = Turnover per hour
KAx24 = Turnover per day
the original authors of this method. These values furthermore,
were somewhat higher than those obtained by the urine method.
This must necessarily be so since this method assumed a uniform
rate of turnover based on that measured between 9.30 AM and /
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and 12.00 noon - a period of increased adrenal activity relative
to the rest of the day; whereas the urine method measured a
production rate which took into consideration all the variations
attendant in the adrenal cortex during the 24 hour period of study.
The plasma levels of this series of 5 normals investigated
during the period of experiment are presented on Table 14.









7.7 5.8 7.3 7.7 6.5
G.E. 8.7 6.6 6.1 5.0 5.8
w. 6.7 3.6 3.1 3.6 3.6
A.W. 5.0 4.6 6.4 6.4 3.2
H.C. 5.0 5.0 5.6
t I
5.6 3.1
The plasma levels of the first specimen taken at 10.00 AM, in all
cases, agreed very well with the normal levels presented on Table 5.
The interpretation of the levels in relation to time was difficult,
simply because the patterns in all cases were irregular. If however
only the 10.00 AM and the 12.00 Noon levels were considered, then it
could be said that in all cases, the levels at 10.00 AM were higher,
indicating to some extent the existence of a diurnal variation and
the state of the adrenal gland during the forenoon and noon periods.
With the establishment of the normal production rate patterns,/
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patterns, the stage was then set to apply these methods to the
investigation of case? in which the adrenal glands were implicated.
A number of (hashing1s, Hirsute, Hypoadralism and miscellaneous cases
were investigated using either one or both these methods. An attempt
will therefore be made to present the results grouped in allied dis¬
ease states.
A series of 13 patients, admitted for further investigation
as possible cases of (hashing*s disease were subjected to the isotope
dilution test and the results, summarized on Table 15, are divided
into two sections, one illustrating those which showed evidence of
increased production rates and the other where normal values were en¬
countered. Also shown on the table will be the results of the urinary
17-ketosteroids and 17-ketogenic steroids carried out simultaneously
with the estimates of production rates so that a comparison might be
made of the sensitivites of the various tests for adrenal function.
Abnormal values in each case were underlined.
Eight of the 13 cases investigated registered a moderate to
a markedly elevated production rate and five showed a normal pro¬
duction rate pattern. Of these eight cases with elevated values,
cases 1,2,3 and 5 have since been treated by adrenalectomy. The
rest, together with those who showed a normal production rate are
still on 'observation' and on a restricted diet regime to reduce the
obesity.
Only in 4 cases was the blood method applied and this test
was discontinued when it was felt that the urine method, which was
much simpler, was capable of giving just as valuable information.
Although in most oases, the 17-ketogenic steroid excretion values
indicated inoreased adrenal activity, the degree of sensitivity was '
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was poor when compared with either of the production rate methods.
Only in two of the eight established cases did the 17-ketosteroid
excretion register a raised level and this, furthermore, was only
of a moderate degree. From all these results it does appear there¬
fore that where the necessary facilities are available, the product¬
ion rate method by isotope dilution appears to be the method of choice
simply because it is a more sensitive index of adrenal function than
either the 17-KGS, which is its next rival, or the 17-KS estimation.
Table 15 F Prod. Rates of 13 cases investigated as
possible Cushing's
i
F PRODUCTION RATE 17-KS 17-KGS
BLOOD, . URINE
Case Age Sex mg/day mg/day mg/day mg/day
1. M.St. 34 F 40.8 22.6 12.9 24.4
2. M.Sr. 39 F 70.0 112.0 16.9 32.6
3. T.D. 38 M 62.4 75-3 19.4 28.6
4. F. 19 M - 51.6 - -
5. R.MC. 39 M - 35.1 23.6 5.6
6. 3. 30 F «. 33.0 11.0 24.7





8. W. 53 F _ 25.9 13.1 17.1
- h—
r. _
9. lsb. 52 M - 17.4
I —
13.8 15.5
10. S.D. 12 F 7.2 11.1 2.6 2.5
11. F.B. 12 F - 17.7 -
12. R. 19 F - 14.9 10.6 11.7
13. w.s. 21 F - 17.2 13.6 20.4
m
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The results from investigation of 4 cases suspected with
hypoadrenalism are presented on Table 16.
Table 16 F Production Rate in 4 Hypoadrenal Cases
F PRODUCTION RATE 17-KS 17-KGS
BLOOD URINE
Case Age Sex Diagnosis mg/24hr mg/24hr mg/24hr mg/24hr
14.J.A. 34 F HYPOPIT. 3.4 0.6 0.8
15.M.R. 56 F Addison1s 4.9 1.7 0.2 NIL
lb.Mit. 48 F Addison's - 8.3 3-9 6.5
17.P.T. 19 M HYPOGONAD. 13.2 17.8 13.5 13.5
The results of cases 14 and 15 fairly clearly showed a reduced pro¬
duction by all the four indices of adrenal function. That of case
16 was somewhat dubious but in the light of the case history and
clinical examination this was thought indeed to be an early oaee of
Addison1s disease and subsequent stimulation tests confirmed the
diagnosis. The results of case 17, at least showed that the patients
adrenals were functioning normally and the information obtained from
ACTH stimulation, dexamethazone suppression and urinary gonadotrophins
suggested that the hypogonadism was of a hypothalamic type and accord¬
ingly he was treated by an implantation of 600 mg of testosterone.
A series of 7 hirsute cases was alao investigated by the
blood and urine methods for F production. It is generally believed
that in this clinical condition, the 17-K3 excretion may be raised
or may lie in the upper normal limit and the 17-KGS which reflect the
corticosteroid output may be in the normal or lower normal region./
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mg/24 hrmg/24 hr mg/24 hr
j • ■ 1—
18,MCI, 34 F 12,2 10.7 7.8 15.6
19.E.C. 23 F 14.8 12.3 11.8 12.0
20.M.D. 48 F 11.8 13.3 6,0 6,0
21.J.M, 23 F JL3.4 11,2 9.9 7.7
22. R, 30 F 11,2 15.0 14.8
23.A.M. 28 F 18.8 13.8 5.9 6.0
24. S,
1
26 F - 26,6 17.3
,
22.9
region. The big question is, is the adrenal gland in this clinical
state 'just1 hyperactive to cause elaboration of 'just excessive1
androgenic steroids and - due to 11-hydroxylase deficiency - just
normal or subnormal corticosteroid output; or is the gland hyper¬
active only in one respect, namely, in the production of androgens
and normal in the secretion of corticosteroids? To answer this
question (or part of it), 17-K3, 17-KGS and hydrocortisone production
rate investigations were carried out and the results are summarised
on Table 17.
The results show that six of the seven hirsute cases regist¬
ered a normal hydrocortisone production by the urine method and
excepting case 24 who had high values in all departments, the 17-KS
and 17-KGS excretions in all cases were also within normal limits.
On the basis of a normal production of 16-30 mg/day by the blood
method, the corresponding values registered by five of the cases /
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cases in this series appeared to be somewhat subnormal with a range
of 9.4 - 14.8 iflg/day. Only case 23 showed a normal production
of 18.8 mg/day. Brooks and Prunty (I960), from a study of the
excretion values of 17-oxosteroids in a large number of hirsute
women, are of the opinion that adrenocortical steroid production is
normal in this clinical condition.
Discussion
Excretion and distribution of ^4o_
The fate of administered hydrocortisone, radioactive or
otherwise, and its excretion rates in a variety of conditions have
been studied by many workers. Hellman et al (1954) administered
0.8 - 1.0 /uc of radioactive material containing O.25-IOQ mg hydro¬
cortisone to normal subjects and to an adrenalectomised subject, both
with and without a maintenance dose of hydrocortisone. The amount
of radioactivity excreted in all cases 3 days after the administration
was of the order of 80$. These results suggest that the rate of
metabolism is independent of tissue requirements and of the amount
present in the body. Furthermore since at the end of the infusion,
only 13$ remained as unaltered hydrocortisone, the rate of metabolism
may be inferred to be rapid. These workers also reported that ex¬
cretion of the radioactive material is prompt; that during the first
6 hours after infusion, 50-60$ of the administered dose will have
been excreted in the urine and that at the end of 24 hours the excretion
may be expected to rans-e from 72-84$. Only 5$ bad been found in
the faeces during the period 24-48 hours and at the end of 4 days
only a small percentage could be detected in the acetone extract of
the faeces. The very small amount of radioactivity ( <.5$) re¬
ported to be present as CO2 in expired air indicated that /
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that degradation of ring A represented only a minor pathway.
Peterson et al (1955) reported that oral absorption is
rapid and complete from the study of peak levels after oral and
intravenous administration of 1-2.5 ;uc of radioactive hydrocortisone
and the similarities of recoveries and rates of excretion of metabol¬
ites. From the rates of diminishing specific activities in 10 normal
subjects, they reported a biologioal half-life of 60-90 minutes and
from urine studies a half-life of 3*8-4.8 hours. Also in this report,
these workers confirmed Hellman's findings that infused hydrocortisone
was metabolised at a constant rate whatever the dose given; but in
patients with cirrhosis of the liver, the half-life of infused hydro¬
cortisone was observed to be longer than that of normal subjects show¬
ing that liver damage affected steroid metabolism. Again it was
reported that 70-82$ of the dose were excreted in the urine during
the first 24 hours or 86-94$, 72 hours after the administration of the
radioactive material. Quite similar results were reported by Plager
et al (1954) who having injected as much as 5 jac in a 24 year old
male subject, reoovered some 3.7 juc in the urine in 48 hours.
Migeon et al (195&) in a detailed study of the cumulative
excretion pattern of radioactive material in urine reported that
2 hours after administration, 2-14$ were recovered; in 4 hours
25-33$; in 8 hours 4O-60;"; in 14 hours 60-70$; in 24 hours 70-83$;
in 48 hours 80-90$ of the administered dose were found excreted in
urine. Cope and Black (1958) reported an excretion range of 76-95$
in 24 hours with a mean of 86 ± 3$. *n this thesis, the urinary
excretion range of 78-95$ with a mean of 83 ± 5$» reported earlier,
agrees well with all the previous findings. However, no attempt
was made to study the excretion in faeces or whether in fact expired
air contained small amounts of radioactive CO2 reported by
Hellman et al.
63
Since the urinary excretion of the radioactive material is
so rapid and the administered dose is small, being about 1 - 5 in
America and 1.25 Aic or less in the U.K., the danger to which the
recipient is exposed to is small; more so if one considers that the
maximum body burden for i8 some 200 >ic.
Of the total excreted in the urine as illustrated on
Table 11, the amounts present in the pHl extract, in the glucuroni¬
dase hydrolysed extract and in the THF and THE zones of the chromato-
gram, were all smaller than those reported by Cope and Black (1958)»
Peterson et al (1955) and Migeon et al (1956). Less than 1$ of the
administered dose was found in the chloroform extract at pHl which
contained mainly the free Cortisol and cortisone. From the same
extract, Cope and Black reported a recovery of 1.5$» Peterson et al
obtained 4$ and Migeon et al 2$. A range of 16-24$ of the admini¬
stered dose was found in the chloroform extract made after p-glucur¬
onidase hydrolysis. Against this value, Cope reported a recovery
of 10-30$ and Migeon obtained 29-40$. The nature and amount of
extracting solvent used and the period of hydrolysis and extraction
appear to account for these differences reported; a point which
once again illustrates the advantages of this isotope dilution tech¬
nique where a poor recovery will not affect the calculation of the
true production rate.
Production Rate from Urine Studies.
When ^4c hydrocortisone is administered, as far as is known,
it appears to be treated by the body in exactly the same manner as
the endogenously produced hydrocortisone. It is therefore expected
to be metabolised equally giving rise to the same proportion of the




activities to the various metabolites. Evidence that this is indeed
the case is forthcoming from the studies of the specific activities
of the abundantly available urinary tetrahydroCortisol and tetra-
hydrocortisone as illustrated on Table 12.
ke has already been shown, the measurement of hydrocortisone
production rate from urine studies depends upon a) the total activity
in the 24 hour urine and b) the specific activity of the hydrocort¬
isone metabolites. A variety of reasons may lead to a low excretion
of and therefore affect the measurement of the true production
rate. Losses may be due to incomplete administration, incomplete
absorption from the alimentary tract, retention in the tissues or
body fluids, impaired renal function and most frequently to incom¬
plete collection, particularly if loss of urine occurs during the
first few hours after administration. If however, the excretion
in 24 hours is found to be 80$ or more, then it would appear that
these interfering factors play only a minor role and that the cal¬
culated production rate represents 80$ or more of the true produc¬
tion rate. In this research, more than 90$ of the cases investigated
registered excretion rates of over 80$, see Figure 17. Barring
renal impairment, an excretion rate of lower than 50$ was inter¬
preted as being due to incomplete collection and a repeat test under¬
taken a week later. The validity of the method to reflect the
actual hydrocortisone production rate with a high degree of accuracy
therefore depends upon a high percentage of the administered dose
being excreted in the urine in 24 hours and upon the determination
of the specific activity of the abundantly available urinary tetra-
hydrocortisone. It does not depend however, upon the isolated THE
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Figure 18 : Plot of specific activities of Plasma vs time.
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the THE zone of the chromatogram be derived solely from the
metabolism of hydrocortisone.
Production Rate from Blood Studies
The specific activities of the plasma hydrocortisone from
the blood samples withdrawn JO, 60, 90, 120, 150 minutes after the
administration of the radioactive material assume a straight line
when plotted on a semilogarithmic graph; see Figure 18. The
whole purpose of these serial determinations is to make possible
the measurement of the specific activity at the time of complete
mixing of the administered radioactive hydrocortisone with the non
radioactive circulating hydrocortisone. This measurement may be
obtained by extrapolating the line of fit to zero time. The ratio
of the specifio activity of the administered dose with that at the
time of complete mixing (j—) represents the degree of dilution of
the administered amount of hydrocortisone (a) and from these two
quantities the miscible pool (A) may be calculated from the isotope
dilution expression :
This rapidly exchangeable pool of hydrocortisone was defined by
Peterson and Wyngaarden as that quantity of endogenously produced
hydrocortisone in the body capable of mixing promptly and thoroughly
with the intravenously injected labelled hydrocortisone. But since
it is also known that hydrocortisone is rapidly metabolised in the
body, this miscible pool, as determined, represents only a fair
approximation of the actual very rapidly exchangeable pool of body
hydrocortisone.
It has also been shown by Peterson and Wyngaarden (1956)
that if the specific activities of plasma hydrocortisone are /
A
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are determined at various intervals during the first 20 minutes
after the administration of the dose, a rapid decline with respect
to time may "be observed as is illustrated by the dotted line on
Figure 18. This very rapid initial decline, which is followed
by a more gradual decline after 20-30 minutes, is attributed to
the distribution of the labelled steroids in the exchangeable hydro¬
cortisone pool. From consideration of the point where the first
slope merges with the second, it may be inferred that equilibration
is complete within 20 or 30 minutes after administration. The
second more gradual declining specific activities which approximate
a straight line on a semilogarithmic plot, results from the body's
continual production of newly synthesized unlabelled hydrocortisone
and the simultaneous removal of the steroid (labelled and unlabelled)
from the pool. If it can be assumed that the size of the miscible
pool is constant during the period of investigation, then the rate
of turnover (K), which represents the amount of endogenously prod¬
uced hydrocortisone added to the pool, may be calculated from the
equation for the first order reaction i
I = loe"*1^,
from which K = log 2 - n
-if- ^fr
where I = the isotope content at any time
Io - M H " " zero time
t^ = half time in hours (t = time in hours)
K = fraction of the pool replaced per hour.
As has already been mentioned, the product of the miscible pool (A)
and the turnover rate (K) represents the turnover of hydrocortisone
expressed as mg per hour. This quantity multiplied by 24 provides
the turnover or production rate in mg/day.
67
In proposing this method, Peterson and Wyngaarden were
cognisant of the various assumptions which have to be made and
evaluated before it could be accepted as valid. Briefly their
method assumes :
1. That the injected hydrocortisone is pure
2. That the injected hydrocortisone does not appreciably alter the
size of the miscible pool and does not disturb the normal meta¬
bolism of the endogenously produced hydrocortisone.
3. That the size of the miscible pool remains constant throughout
the period of study.
4. That the rate of synthesis of hydrocortisone equals the rate
of transformation of the steroid
5. That the administered radioactive hydrocortisone is handled like
the endogenous steroid, and that there is random disappearance
of both the endogenous and labelled steroid.
6. That the mixins: of the injected steroid within the pool is
homogenous and is rapid compared with its metabolism
7. That the rate of metabolism of the steroid is proportional to
its concentration
8. That the readioactive steroid does not re-enter the pool
9. That the isolated plasma hydrocortisone is pure.
In this research, a few of the assumptions have been tested
while others have been inferred to be legitimate. The accompanying
note on the ampoule containing the 4-14q Cortisol, when it arrived
from America, stated that it was 95$ pure. This was checked by paper
chromatography in the Bush^ system and it was found that 90-98$ of
the radioactivity moved as Cortisol. This was taken to mean 100$
purity and no correction was made in the calculation. The amount
of hydrocortisone in the dose in every case ranged from 10-20 Jig /
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10-20 jug and this certainly would not alter appreciably the size of
the pool or disturb the normal metabolism of the steroid. It has
been suggested that the constancy of the size of the pool may, to
some extent, be Inferred from the constant plasma levels of hydro¬
cortisone during the period of study. Data obtained from 25 investi¬
gations render this suggestion most difficult to accept partly because
some patients show no significant variation in plasma F level between
10 AM and 12 noon while the majority of cases show a definite tendency
to decline. Evidence that hydrocortisone once removed from the mis-
cible pool does not re-enter the pool as unaltered hydrocortisone is
forthcoming from the work of the original authors of the method.
These workers, after the administration of a trace Quantity of the
labelled steroid, compared the specific activities of the circulating
hydrocortisone which were sampled simultaneously from a peripheral
vein and the hepatic vein by catherization. The specific activities
obtained from both sites were similar for at least three hours, indi¬
cating no apparent reversible concentration of hydrocortisone by the
liver. Lastly data have been obtained in this research showing- that
the eluted steroid from the Buship chromatogram registered an identical
absorption - fluorescent spectra with that of authentic hydrocortisone
indicating that the isolated steroid is indeed pure hydrocortisone.
Cushlngs Syndrome.
Even when all the signs and symptoms associated with Cushing's
syndrome are present, diagnosis still needs to be confirmed and the
extent and nature of the adrenal hyperactivity evaluated by resort
to biochemical investigations. When the diagnosis is established,
the current treatment appears to be to subject the patient to adrenal¬
ectomy or to pituitary irradiation by ^yt* Apart from the /
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the preliminary investigation for the presence of impaired glucose
tolerance and electrolyte disturbance, the biochemical investigations
usually carried out are the measurements of the urinary 17-KS, 17-KGS
and where laboratory facilities permit, the estimations of urinary
free Cortisol, plasma Cortisol and hydrocortisone production rate.
It has often been reported that the urinary 17-ketosteroids
are moderately raised in Gushing's syndrome. In the 13 cases in¬
vestigated (see Table 15) only 2 showed such an elevation while the
rest registered a normal excretion pattern. Cope and Black (1959)
investigating 12 cases of Cushing's disease, reported an insignificant
rise of the mean value of 1.4 times the normal. Levell et al (1957),
from 7 Gushing's cases investigated, reported a 17-K8 excretion range
of 4-40 mg/day. In fact only one of the 7 cases showed a raised
value; the rest were well within the normal range. While normal
excretion values of 17-KS do not exclude the possibility of Gushing*s
syndrome, high values, such as 100 mg/day or more as reported by
Dorfman and Shipley (1956), not only confirm the diagnosis but often
raise a strong suspicion that the cause of the hyperadrenalism is the
existence of a tumour. The moderate increase in 17-KS in other in-
-i
stances is due mainly to the 11-oxygenated ketosteroids which are
metabolites of Cortisol and, to a lesser degree, to the 11-deoxy group
which are metabolites of adrenal androgens.
From measurements of urinary 17-ketogenic steroids and 17-
hydroxyoorticosteroids, Cope and Black (1959) reported a 4-fold in¬
crease in Cushing's cases. Levell et al (1957) reported a range of
6-34 mg/day in 7 patients, four of whom showed elevated values. Six
out of the thirteen cases reported on Table 15 registered higher than
the normal excretion values for 17-KGS. Prunty (i960) reported /
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reported that the level of 17-KGS in Gushing's syndrome is frequently
found to be slightly elevated or within the upper normal limits and
found this to be so in six out of his eighteen cases. He further
suggested that excretion of these steroids is particularly liable
to fluctuate from day to day in this syndrome and that if determin¬
ations are repeated, elevated values may be observed. For example,
when nixie determinations were carried out in one patient, values
varied between 11 and 40 mg/day.
The measurement of the urinary excretion of free Cortisol
as a good diagnostic test for Gushing's syndrome has been proposed
and supported by a number of workers. Cope and Black (1959), from
a study of the Cortisol output in hospitalized patients, observed
a normal excretion of 0-100 pig/day with a mean of 43 pg/day. In
the 12 cases of Gushing's syndrome they investigated the excretion
of this free steroid was raised some eight times the normal value
giving a mean of 320 pig/day; only in 2 cases was there a small over¬
lap with the normal range. Having also studied the 17-K8 and 17-KGS
excretion patterns simultaneously, they suggested that the estimation
of urinary Cortisol is at least twice as sensitive in detecting the
hyperadrenalism of Cushing's syndrome as is the 17-KGS assay. Similar
findings were reported by Ross (i960) who from a study of eleven pat¬
ients observed excretion values up to 710 pig/day as compared with his
normal of 3-48 >ug/day. Cope and Black suggested that the increased
free Cortisol found in the urine may be related to the change in
the binding capacity of the Cortisol to plasma proteins at different
plasma concentrations. Mills (1959) found that the circulating
Cortisol was 95$ bound at 37°C when the plasma concentration was
10 pigfe, 80$ bound at a plasma concentration of 40 pig$ and 72$ bound
when the plasma concentration was 80 pig$>. Thus in Cushins's /
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Cushing's syndrome the binding capacity is reduced leaving a much
greater proportion of the freely diffusable oortisol available for
renal filtration.
On the basis of a normal plasma range of 4-8 (60$ recovery),
the 10 A.M. plasma hydrocortisone levels from the first 3 Gushing's
cases on Table 15 registered 13.1, 14.0, and 11.8 )&&$>, thus providing
some evidence that levels are moderately raised. Although hieb. levels
of plasma oortisol are expected in Gushing's syndrome - and indeed a
level of 135 was reported by Sweat (1955) - often, normal levels
have been reported in many cases. Eik Nee et al (1955) have drawn
attention to the fact that the normal diurnal variation is often lost
in Gushing's syndrome and this may be of diagnostic importance espec¬
ially when values lie within the normal range. Prunty (i960) re¬
ported that in his 12 Gushing's cases, plasma levels of between 3 PS
and 56 jug$ were obtained; only in 6 cases was the upper limit of
normal exceeded. This worker feels that in the interpretation of
plasma values, allowance must be mads for the rapidity with which the
level may fluctuate from time to time as a result of emotional and
other stimuli or from unknown causes. For this reason many feel that
technicues Involving the measurement of excretion of metabolites over
a long period, usually 24 hours, are of greater value in presenting an
integrated picture of adrenal activity.
Tests of adrenal stimulation and suppression have been freq¬
uently used either to confirm the diagnosis or to differentiate ad¬
renal tumour from hyperplasia. It is believed that patients with
Cushing's syndrome due to hyperplasia are extremely responsive to
stimulation with ACTH; those with adrenal adenoma show a lesser
degree of responsiveness, whilst those with carinoma are likely to
be even more unresponsive because of their autonomous nature /
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nature (Lindsay et al2956; Nabarro et al I958; Birke et al i960).
Suppression tests have been carried out with cortisone, 9 *-fluoro-
hydrooortisone, dexamethazone, and more recently with SU4885 (Liddle
1959). 'hile the first three suppressors operate by way of inhibi¬
ting- ACTH secretion, SU4885 operates by inhibiting the synthesis of
Cortisol at the stare of 11-hydroxylation. This results in a rise
in ACTH secretion and a concomitant increase in the urinary 11-deoxy
Cortisol (Compound S). If the tumour is autonomous, the expected
rise of substance S in urine does not occur. Even in these differ¬
ential teats, exceptions such as patients with adenoma responding
to ACTH stimulation and oases with hyperplasia not responding to
cortisone suppression have been reported (Brooks et al 1957; Byren-
furth et al (i960) suggesting that these tests cannot be used with
certainty to distinguish between hyperplasia, adenoma and carcinoma;
although the type of response observed may reveal adrenal abnormal¬
ity when compared with the normal response.
On the basis of the various adrenal function tests (17-K3,
KGS, Plasma F, ACTH Ctiraulation, Dexaaethazone suppression etc.)
carried out on the 13 patients investigated as possible Gushing*e
cases (Table 15), the production rate by ^^C dilution technique
provides the best index of adrenal activity. Eight of the 13 cases
have been found to have a raised production rate with a range of
between 22.6 mg and 112.0 mg/day. A much higher production range
has been reported by Prunty (i960). In his 12 Gushing'© cases,
& production of between 39 and 420 mg/day was encountered - the two
highest levels of 210 and 420 mg/day oocuring in patients who had
bronchial carcinoma with metastases. The great advantage of the
test over the 17-KGS, which is its nearest competitor as an
index of adrenal function, particularly in Gushing's syndrome is /
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is the significantly high production rate encountered in the face of
a normal or moderately elevated 17-KGS - values which are convincing
enough for the clinician to warrant positive - as against conserv¬
ative - treatment immediately.
Hirsutism.
The excretion of urinary steroids in hirsutism has been
thoroughly investigated more recently by Prunty et al (1958), Brooks
et al (i960) and Brooks and Prunty (i960). These workers, in their
investigations of the occurence of hirsutism and virilism in women
after the onset of puberty, differentiated between three types of
hirsutism; simple hirsutism, adrenogenital syndrome manifest after
puberty and Stein-Leventhal syndrome. This differentiation may be
made on clinioal grounds and on urinary steroid investigations before
and after corticotrophin stimulation. According to Prunty (i960),
the clinical features which may be suggestive of adrenogenital syn¬
drome are usually shortness of stature with broad shoulders, small
mammal and clitoral enlargement; those suggestive of the Stein-
Leventhal group are prolonged intervals between menstrual periods
or amenorrhoea, anovulation and sterility with some degree of ovarian
enlargement demonstrable olinically or radiologically. Other hirsute
cases not belonging to either of the two groups just described are
referred to as idiopathic hirsutism and very often the features which
differentiate this group from the other two groups are mental depress¬
ion and a family history of hirsutism.
Biochemically, all three groups may show some elevation of
urinary 17-ketosteroids (but always below 30mg/day) and no clear
distinction can be made on this basis. However, from the figures of
Brooks and Prunty (i960), the increase appears to be greatest in
the adrenogenital type, less in the simple hirsute group and /
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and least in the Stein-Leventhal group. All three srroups showed
an exaggerated response of 17-ketosteroids to ACTH stimul tion -
the exaggeration being least in the adrenogenital group. The 17-
ketogenic steroid exoretion in all three groups was within normal
limits and the response of these steroids to ACTH was comparable with
the normal response; and again the adrenogenital group showed the
least response comparatively. The best test to differentiate between
the three groups appeared to be the measurement of the resting urinary
pregnanetriol exoretion. In this respect, the adrenogenital group
showed elevated values of 4-10 mg/day as compared with 1-3 mg/day
excreted by the other two croups (normal beinr 1-2 mg/day). The
high pregnanetriol excretion was interpreted as beinr? the result
of a deficiency of 21-hydroxylation of 17-hydroxyprogesterone in the
synthesis of hydrocortisone. Under ACTH stimulation, the excretion
of this steroid was markedly increased in the adrenogenital type as
expected, but the response in the other two groups was variable.
From all these results together with those obtained from a
detailed study of the individual urinary 17-ketosterold excretion
before and after ACTH stimulation, Brooks and Prunty (i960) suggested
that in post pubertal hirsutism, there is one type which is analogous
to congenital adrenal hyperplasia in which there is a relative in¬
ability to synthesise Cortisol with a consequent compensatory increase
in corticotrophin production. In this clinical condition, there is
a relatively small exoretion of Cortisol metabolites in the urine
with a concomitant increased excretion of pregnanetriol, 17-hydroxy-
pregnanenolone, 11-oxoprewianetriol and 11-hydroxyandrosterone.
Furthermore, following A.CTH stimulation the response in the excretion
of Cortisol metabolites is poor but that of pregnanetriol excretion
is markedly elevated and therefore of diagnostic importance. /
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importance. Patients with simple or idiopathic hirsutism have a
tendency to excrete relatively more of the 17-ketosteroids derived
from precursors compared with those derived from Cortisol and
results, particularly from the study of pregnanetriol excretion rates
before and after ACTH stimulation, seem to indicate that the under¬
lying cause is not due to an impairment of Cortisol seoretion with a
compensatory inorease in corticotrophin but to a potentiation of the
production of adrenal androgens. In the Stein-Leventhal group, the
steroid excretion patterns which are similar to those of the simple
hirsute group, suggest that besides ovarian there is also an adrenal
involvement since upon stimulation with ACTH, the increased 17-KS
found are due mainly to the increase in the dehydrofcpiandrosterone
and ll-hydroxyandrosterone fractions which appear to be exclusively
of adrenal origin.
Against a background of such useful information on hirsutism
and in the absence of data from ACTH stimulation and pregnanetriol
excretion, no attempt was made to categorise the 7 cases investigated
into the group each ought to fall. But data on Table 17 show that
six out of the seven hirsute cases registered a normal hydrocortisone
production rate by the urine method. Furthermore, in the absence of
a normal production range - for women of comparable asre group - by
the blood method, five of the oases registered a subnormal production
when evaluated on the basis of a normal range of 16 - JO mg/day.
Whether these blood production values are normal values or indeed
subnormal values, the answer seems to lie in the hands of the research
worker who may be fortunate enough to obtain, for comparison, a normal
production range from healthy adult femal volunteers. However, the
striking feature in all these cases investigated is that their
miscible pools (A) were generally found to be larger than normal;
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normal; but because their turnovers (K) were smaller than normal as
judged by a biological half life of greater than 2 hours (Normal 60 -
90 mins.), the calculated production rates appeared to be subnormal.
The presence of a large miscible pool in these hirsute oases, in
the absence of adrenal hyperactivity, seems to suggest a delayed
metabolism of the circulating steroid and this would account for the
diminished turnover rate of hydrocortisone. But a subnormal estimate
of production by the blood method and a normal estimate of production
by the urine method are still incompatible. Certainly, further in¬
vestigations using the blood method should be rewarding in throwing
more light on this apparent delayed steroid metabolism and in deciding
once and for all the true pattern of hydrocortisone production rates
in the various types of hirsutism.
Comparative Indices of Adrenal Function.
The degree of sensitivity of the various adrenal function
tests may be judged from the findings on Tables 15, l6, 17. It will
be noted that the production rate studies by isotope dilution are the
most reliable. In an attempt to evaluate all these tests, Cope and
Black (1959) found that there is very poor relationship between the
hydrocortisone production rate and the 17-K8 excretion rate. They
cited instances when the 17-KS output was 25 mg/day, the production
rate was 10 mg/day; and that an output of 30 mg/day occured in a
patient when his production rate was 225 mg/day. This poor corre¬
lation, though not so dramatic, also occured in the Cushing1s cases
reported on Table 15. With the 17-KGS, the relationship was re¬
ported to be more encouraging. At high rates of adrenal activity
the exoretion of 17-KGS is approximately half that of the daily
production, but in low normal or moderately raised adrenal activity
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activity the relationship is poor. In this research, of the eight
Gushing's cases with elevated production rates, 5 registered a raised
17-KGS and 2 a raised 17-KS. When the production rates were normal
or diminished as illustrated on Tables 16 and 17, the 17-KS and 17-
KGS excretion values were also normal or diminished. But the extent
of increased or decreased values was greatest in the production rate
method.
Other Production Rate Values.
Since the introduction of this 14o test for adrenal function,
the hydrocortisone production rates in many clinical conditions have
been investigated. Cope and Black (1958) reported that in a series
of 12 tests on persons undergoing adrenal stimulation with ACTH, the
mean recovery of the administered ^4c was 76.4$ *n 24 hours and the
hydrocortisone production ranged from 22 mg to 257 mg/day with a mean
of 99 mg/day. In contrast, a series of 4 oases of gross hypoadrenal-
ism due to hypopituitarism or Addison's disease gave a mean 24 hr ex¬
cretion of 81$ with a daily production of 0.8 to 1 mg. In a series
of six active disease oases (lymphosarcoma, carcinoma breast, (2)
rheumatic fever, advanced tuberculosis, advanced Hodgkin'9 disease),
the oortisol production ranged from 10 - 25.8 mg/day with a mean of
18.1 mg as compared with a daily mean of 12.8 mg, suggesting that
in these active disease states, some adrenal stimulation had occured.
In three other subjeots with well marked hyperthyroidism, the mean
production of 21.9 mg/day pointed to a greater degree of stimulation
and this is not surprising in view of the increased metabolism in
these patients. In three patients with advanced hepatic cirrhosis
the mean estimate was 6.7 mg/day, a figure suggesting that the output








































































1 Ac. Renal F
IChJaundia
78
normal. In 1959* these same workers studied the production rates
in a series of 8 women during the last month of normal pregnancy and
reported a production of between 20 and AO mg/day indicating that
in late pregnancy the production is increased from 2 to times the
non pregnant fis:ure.
Peterson (1959) also recorded similar increases by the method
of blood determination during ACTH stimulation and in hyperthyroidism.
A reduced production was observed in myxedema, in cirrhosis and in
prolonged salicylate or oestrogen therapy. To this interesting pool
of production rate values are now added further information obtained
from this research regarding the production rates in dishing's syn¬
drome, in hirsutism, in some hypoadrenal states and in the post surg¬
ical state. This last named condition is the subject of investigation
and discussion of the next, chapter.
To close this chapter, an attempt is made to summarise the
results of all the investigations carried out thus far by means of
some graphical representations. Thus, figure 19 summarises the
production rates measured from urine studies and Figure 20, those
from blood studies.
Chapter IV : The adrenal and metabolic response to Surgery
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The adrenal gland and the metabolic response to surgery.
General.
From previous work undertaken in this laboratory, it has
been observed that the usual changes which occur in the immediate
period following surgical operation are 1) the occurence of oliguria,
2) the increased plasma levels of hydrocortisone and excretions of
urinary steroids and 3) a sodium retention with a concomitant pot¬
assium and nitrogen depletion. It is currently believed that these
metabolic changes are necessary and have been designed by the body to
maintain osmotic equilibrium between the various fluid compartments,
to withstand stress and to provide the energy and raw materials for
repair and healing of the wound.
The occurrence of oliguria, suggesting involvement of the
kidney and alterations in water and electrolyte metabolism, was known
to occur following surgical operations over fifty years ago (Pringle
1905) but little importance was attached to this observation then,
Stewart (1955) suggested that this lack of interest might have been,
in part, due to the belief that a low urinary volume only indicated
a reduced intake of water and in part due to the technical difficulty
of studying water and electrolyte metabolism at that time. But later
on when it became evident that metabolic changes, other than oliguria,
did indeed occur - mainly from the urinary excretion studies of nit¬
rogen, potassium and sodium - much interest was devoted to these phen¬
omena with a view a) to formulate a rule in the management of the
post-surgical patient and b) to investigate the mechanism by which
these metabolic changes operate. As a result of such research
carried out by numerous workers from both sides of the Atlantic, many
of the metabolic changes and knowledge concerning the utilisation /
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utilisation of fluid, electrolytes, carbohydrates, nitrogen and
fat in the immediate post—operative period are now well documented.
But the problem is by no means solved yet; for one, the
mechanism responsible for the changes involving electrolyte and
nitrogen balance is still uncertain and for another, the alleged
increased secretion of adrenal corticosteroids from urinary excretion
and plasma level investigations post surgically, still needs to be
supported whenever a more reliable test for adrenal function i9
available. Thus, this section of the thesis is concerned with the
measurement of the endogenous hydrocortisone production before and
after surgery and, if possible, to interpret the role of the adrenal
gland in the light of other metabolic changes simultaneously measured.
The adrenal response to surgery.
One of the earlieat observations suggesting that the urine
of post-operative patients contained increased amounts of cortin-like
activity was made by Weil and Brown (1939, 1940). These workers in¬
jected the extracts of such urine into adrenalectomised rats, sub¬
jected them to a cold environment and measured their mean survival
time. The increased survival time observed was taken to mean the
presence of inoreased activity in the urine extract and therefore
manifestation of increased adrenocortical activity as a result of
operation.
Evidence that human urine did in fact contain a substance
or substances with some of the properties of the hormones of the
adrenal cortex came from the works of Perla and Marmosten - Gottesman
(1931), Grollman and Frior (193^) and Anderson et al (1938). These
workers injected the benzene-soluble material from urine into adrenal¬
ectomised rats and observed that the same effects could be brought /
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brought about by injection of adrenal extracts. Dorfman (1943)»
in a series of investigations, showed that the extracts of pooled
urine had all the biological activities of extracts of adrenal
cortex, namely, that urine extracts could - in the adrenalectomised
rats - maintain life, protect against cold, deposit liver glycogen
and protect against water intoxication. A year later (1944^)»
these workers reported that the extracts of urine from seven Aadison-
ians showed no demonstrable activity; that although urine extracts
of monkeys (1944&) with intact adrenals or after castration contained
substantial adrenocortical activity, this activity was lost when they
were adrenalectomised. The information from all these investigations
strongly suggested that the active principles in the urine extracts
were, in fact, hormones which were mainly elaborated, not by the
testes or ovaries, but by the adrenal cortex.
Venning et al (1943,1944), using the life maintenance property
of urine extracts of post-operative patients and applying the cold
protection and liver glycogen deposition tests as indices of adrenal
function confirmed the earlier observations of Weil and Brown. They
concluded that post-operative patients excreted as much as thirty
times the amount of cortin-like substances as compared with normal
persons.
Shipley et al (194&)» reviewing the evidence of increased
adrenocortical activity after operation, concluded that, despite
the poor specificity and recovery given by the biological methods
then in use, the large amounts of cortin-like substances constantly
found in urine after surgery was convincing enough to suggest in¬
creased adrenocortical activity.
The decrease in the number of circulating eosinophils often
observed by many workers in the immediate post-operative phase /
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phase was also considered to be suggestive of increased activation
of the adrenals. Roche et al (1950) observed that the number of
eosinophils fell rapidly within one or two days following operation
and that in a few cases, they disappeared completely. The severity
of the operation seemed to have a bearing on the intensity of res¬
ponse. The conclusion that this response was solely due to increased
adrenocortical activity becomes doubtful when it is now realised that
increased secretion of adrenaline at the time of surgery can also
cause an occurence of eosinopaenia.
The excretion pattern of urinary 17-ketosteroids following
operation has been observed widely. Forbes et al (1947) reported
that the increase, when it did occur, was evident 24 or 48 hours
after operation. Subsequently a gradual fall in output occurred and
four or five days postoperatively.the values were frequently below
the preoperative range. The return to normal values was variable
and occurred some 7-10 days after operation. Similar reports were
forthcoming from the investigations of Ferry and Gemraell (1949),
Venning and Browne (1947), Mason and Engstrom (1950), Hardy and
Rawdin (1952) and Birke et al (1955).
With the introduction of improved methods for the estimation
of adrenal steroids in biological fluids, further evidence became
available. In 1953, Thorn et al, using a method which measured both
the free and conjugated 17-hydroxycorticosteroids, reported finding
increased values in urine of patients after major operation. These
workers also added that minor operations evoked no such increase.
Tompsett and Smith (1954) investigated the urinary excretion patterns
of 17-KS, 17-KGS and ASFS (acid stable formaldehydogenie steroids)
before and after surgery. Their results from measurement of 17-KS
and 17-KGS indioated a variable response, but those based on the /
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the measurement of A9FS showed a definite 2 to 3-fold increase
after operation.
An increase in the excretion values of tetrahydrocortisol
(THF) and tetrahydrocortisone (THE), the two major urinary metabolites
of hydrocortisone, was reported to occur after major surgery by Cope
and Hurlock (1954). The measurement of these two 0 -glucuronidase
hydrolysable steroids as an index of adrenal function was also used
by de Courcy et al (1953) who, from 10 normal male urines, found
normal mean values of 212 ug/24 hr for THF and 1.5 mg/24 hr for THE.
Gold et al (1958) studied the excretion ratios of these metabolites
in surgery (and in a variety of other conditions) and reported find¬
ing increased values of THF and THE.
In a somewhat extensive study of the adrenocortical response
to surgery, Reece et al (1957), observed increased excretions of 17-
OHCS in the postoperative period lasting from 2-7 days. Of their
48 patients undergoing major and minor surgery, 19 were submitted
to partial gastrectomy, 16 to inguinal herniorraphy and 13 to lapar¬
otomy. The total urinary 17-0HCS were estimated by the Norymberski
technique and a pre-operative upper limit of 16.2 mg/day was used
for comparison with the post-operative excretion values. Following
partial gastrectomy there was an increase of corticosteroid output
with a mean peak excretion of 40 mg/day occuring usually on the third
post-operative day. The response in inguinal herniorraphy was less
marked with a peak mean of 25 mg/day and that following laparatomy
was very variable.
Likewise Markley et al (i960) measured the urinary corti¬
costeroid output in 29 patients who underwent major surgery. 17
OHCS were measured by application of the Porter Silber reaction and
17-KS by the microtechnique of Vestergaard (1951). Over 75^ of /
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of the oases showed elevated excretions of 17 0HC8 after operation
but the excretions of 17-KS on the other hand were rarely elevated
above the preoperative value. The administration of ACTH in the
post-operative period produced further increases In the excretion
of the urinary corticosteroids and this finding- strongly suggested
that adrenocortical response was not maximal even after major surgery.
When Nelson and Samuels (1952) described their satisfactory
method for the estimation of plasma 17 OHCS much useful Information
was obtained from measurement of plasma steroids before, during and
after operation. Frankseon et al (1954) measured the plasma levels
of 27 patients undergoing surgical operation and reported that on
the morning of the day of operation, th ; plasma steroid levels were
usually slightly elevated and that following the preoperative prepar¬
ation, the level further increased. They attributed this immediate
preoperative increase to the stimulation of the adrenal glands caused
by the additive effect of tension, preoperative treatment and anasth-
esia. Immediately following surgery, all their patients showed a
marked elevation of blood 17-OHCS, A peak level was observed to
occur some time between 24 and 48 hours after the operation. This
was followed by a rapid fall to subnormal values, but returning to
normal within f2 hours following operation. Similar inform? tion
was forthcoming from the laboratories of other workers (Sandberg et al
1954; Elman et al 1955; Mittleman and Barker 1956; Sandberg et al
1956; Helmreich et al 1957; Marks et al 1959; Markley et el I960).
More direct evidence of increased adrenal activity post¬
operatively comes from the work of Hume and Nelson (1954). These
workers observed an actual increase in adrenal venous output of 17
OHCS after operation in dogs; oontrol values being obtained by leav¬
ing the cannulae in situ and measuring the blood levels of steroids /
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steroids during the convalesoent period. Hardy et al (1957), by
means of timed collections of adrenal vein blood also found higher
levels of hydrocortisone secretion in patients at operation.
The importance of the liver in the removal of hydrocortisone
from the circulation has already been discussed in the previous chapter
Other facts which need to be added in this respect may include the
finding of Nelson and Harding (195^), who having injected cortisone
5
intravenouly into dogs, found that the steroid was removed very rapidly
from the pool and pre-injected levels of 17 OHGS were observed sixty
minutes later. These workers also found a marked difference across
the liver when arterial and venous blood samples were assayed for
steroids. Tomiza et al (1954) found that after an injection of
cortisone into intact and hepateotomised mice, blood steroid levels
rose in both groups, but the rate of disappearance of the injeoted
steroid from the circulation was slower in the hepatectomised group.
With the finding that blood contained f-glucuronidase hydrolysable
steroids by Bongiovanni et al (1954) and evidence of inactivation of
physiologically active adrenal steroids when incubated with sliced rat
or human liver (Heaven 1955), the role of the liver in the metabolism
of adrenocortical steroids became established. To test this role
further, Tyler et al (1954) measured simultaneously the liver function
by bromosulphthalein excretion and the inoreases in free blood steroids
in their patients undergoing operation. Their results suggest that a
relationship Indeed exists between the condition of the liver and the
level of free blood steroids; the greater the liver damage, the
greater the steroid rise after surgery.
The administration of anasthesia during the preoperative
preparation being responsible for a slight increase in blood steroid
levels was mentioned earlier in this chapter. In a detailed /
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detailed study of the effects of different anasthetios on blood
17 OHCS, Virtue et al (1957) showed that 15 out of their 35 patients
who received ether as the anasthetic registered a definite increase,
but of those who received cyclopropane or thio-penthol-nitrous oxide
or spinal anasthetic, only a small proportion showed similar increases;
thus pointing out that anasthetic agents differ in their effects,
presumably, depending upon the effect the agent exerts upon liver
function.
The conjugated blood steroids were also reported to increase
following surgery. Hardy and Turner (1956) reported finding a rel¬
atively greater increase in the conjugates than in the free steroids
post-operatively, implying an increased rate of liver conjugation.
Helmreich et al (1957)» on the other hand, in a study of 12 patients
undergoing major surgery, observed a variable response in the conjug¬
ate levels. In some patients a pronounced rise was noted at a time
when the free 17 OHCS reached peak levels and in others, there was a
virtual absence of such response. This finding suggested that liver
conjugation of the steroid was impaired in some patients following
surgery but not in others. More recently Steenburg et al (1961)
compared the response of serum free and conjugated 17 OHCS in normal
subjects under ACTH stimulation to the response in patients after
subtotal gastrectomy. They observed a) that the rise in the serum
level of the free steroid was more rapid following gastrectomy than
that following adrenal stimulation in the normal subject and b) that
the rise in the serum level of the conjugates was more gradual in
the surgical patients. From these interesting observations, these
workers suggested that the elevated blood levels of free steroids
following surgery are due in part to delayed metabolism and in part
to stimulation of the adrenal cortex.
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An interesting but totally different kind of response was
observed to occur during hypothermic operations. Swan et al (1957)
measured the free and conjugated 17 OHCS in plasma during the course
of anesthesia, body cooling, hypothermic surgery and post-operative
recovery in a group of 21 patients undergoing major oardiovascular
surgery. The pattern of adrenocortical response obtained, suggested
that the induction of hypothermia by ice water immersion produced
a moderate activation of the adrenal cortex, but when hypothermia
was established, even severe trauma failed to produce additional
increase in adrenocortical secretion; a finding which is in direct
oontrast to the changes observed during surgery in nomothermic patients.
Upon rewarraing however, the levels of the free steroids promptly rose
but those of the conjugates remained unchanged. These authors suggest
that the failure of the plasma 17 OHCS to rise during surgery resulted
from a suppression of adrenocortical secretion due to hypothermia.
This concept, they added, was supported by the fact that hypothermic
dogs also demonstrated a marked decline in adrenal blood flow, in the
rate of Cortisol output from the adrenal gland and its ability to re¬
spond to ACTH stimulation.
The evidence accumulated during the last decade concerning the
adrenocortical response to surgery strongly suggests 1) that major
surgical operations augment the activity of the adrenals by way of an
increase in endogenous ACTH secretion; 2) that adrenal activity is
not maximal under these conditions; 3) that diminished liver metab¬
olism following surgery exaggerates plasma steroid levels and brings
about a somewhat delayed excretion of steroid metabolites in urine;
and 4) that during the hypothermic phase, adrenal activity is supp¬
ressed due to its inability to respond to ACTH stimulation.
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Nitrogen, water and electrolyte metabolism following surgery.
Nitrogen.
Following the occurrence of oliguria, the next metabolic
change which attracted attention was the constant finding of
increased nitrogen excretion in the urine of the post-operative
patient. To Cuthbertson must go the credit of being the first to
study systematically the metabolism of nitrogen following trauma.
In 1930, he observed that increased amounts of nitrogen were exoreted
by his post-operative and post-fracture patients. During this period
of increased nitrogen loss which persisted from 7-10 days, he also
studied the excretions of phosphorus and sulphur from which he con¬
cluded that the source of these increases was the tissue protein.
This period of excess protein oxidation was referred to as the "protein
oatabolic phase." The effects of immobilisation and starvation as
possible oauses for this increased nitrogen loss were also examined
and it was found that they contributed very little; a finding later
substantiated by Howard et al (1944). In 1932> Cuthbertson reported
that anasthesia alone did not produce a marked nitrogen loss. Further¬
more, although there appeared to be some correlation between the ex¬
tent of injury and loss of nitrogen, he believed that this increased
loss was not solely due to tissue breakdown in the traumatised area,
but the result of a generalised rapid protein catabolism to provide
material for tissue repair.
Another ooncept to account for this post-operative nitrogen
loss was introduced by Albright (1943). This worker postulated that
the increased nitrogen excretion after stress of any kind was due
to an imbalance of hormones; namely, that during this period, the
anti-anabolic ' S' hormone was greatly in excess of the anabolic /
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anabolic "N" hormone and that ingested protein was not utilised,
the amino acids passing through the liver and being excreted by
the kidneys. To this view, Peters (1944) and Grossman et al
(1945) also subscribed. But the finding by Wilkinson et al (1950)
that urea and not amino acid was the major nitrogenous constituent
in the urine in the post-operative period renderfed this anti-anabolic
concept questionable if not invalid.
Werner (1948) on the other hand maintained that the increased
nitrogen excretion was due to starvation since in the Immediate post¬
operative period the nutritional intake was either absent or invariably
inadequate. And although a few years earlier (1944) Co Tui et al
claimed to have abolished the negative nitrogen phase after gastrect¬
omy by the administration of large quantities of amino acids and
protein hydrolysates, Wilkinson et al (1950) were unable to confirm
Co Tui's findings. These last mentioned workers support the view
that the Increased nitrogen loss following operation was due mainly
to the effect of trauma on the metabolic processes and that the food
restriction in the immediate post-operative period contributed very
little to it.
It is now believed that the extent of nitrogen loss after
operation depends upon the nutritional state of the patient. Many
workers (Levenson et al 19451 Wilkinson et al 1950» Moore and Ball
1952) have reported that patients who have lost weight pre-operatively
as a result of malnutrition or disease, excreted less nitrogen post¬
operatively than those who were well nourished. It would thus appear
that to starve the patient for some time before the operation is
the most effective way of abolishing or minimising the post-operative
nitrogen loss. Indeed, earlier attempts to abolish completely the /
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the catabolic phase succeeded only in increasing the gross amount
of nitrogen excreted but did not alter the overall negative nitrogen
balance. Stewart 1955, among other workers, is inclined to believe
that this "oatabolic phase" following surgery cannot be abolished;
that it represents an inherent response to injury and is a physiolog¬
ical rather than a pathologioal prooess which should not be discouraged
or interfered with.
Oliguria.
The early belief that a decreased urinary volume following
surgery,only reflected a reduced intake along with a large fluid
loss at operation led to the practice of saline administration
routinely to all surgical patients. When later it became evident
that these patients were not able to tolerate large volumes of in¬
fused saline and often developed oedema, sometimes with fatal results,
Coller et al (1944), who earlier on proposed their 'clinical rule'
as a rough guide regarding the amount of saline to be administered
to the surgical patient, strongly oriticised the evil effects of
excess saline administration and advocated the discontinuation of
the practice of the old rule.
Many workers have observed that the severity of the operation
bore some bearing on the extent and duration of the oliguria; the
more severe the operation, the more marked and prolonged the period
of oliguria. Even when blood transfusions, calculated to replace
the blood lost, were given at the time of surgery, oliguria was seen
to occur. Cooper et al (1949) reported that specific gravities of
the post-operative urines were of the same order as those in which
no attempt had been made to replace the fluid lost. This clearly
showed that the oliguria did not appear to be entirely due to the j
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the state of hydration of the patient.
That the effects of anesthesia were not the cause of the
oliguria was shown by Coller et al (1943) a^d by Mayer (1950).
From an extensive study of the mechanisms of the kidney in an
anasthetised person not subjected to operation, these workers
were able to demonstrate that there was no deleterious action of
the anasthetic upon the kidney parenchyma.
A decrease in the glomerular filtration rate and renal
blood flow to account for the oliguria was suggested by Elman
et al (1949) who obtained a diminished creatinine output following
operation in their patients. Habif et al (1951) further suggested
that consequent upon this diminished filtration rate, there was also
the tendency of increased reabsorption of water by the renal tubules
to occur. Ariel and Miller (1950), while agreeing that the oliguria
was not due to any intrinsic renal dysfunction or renal damage, sugg¬
ested that the primary cause of the decreased glomerular filtration
and renal blood flow was a result of hormonal imbalance following
surgery.
Sodium.
The occurence of a low or even absent urinary sodium in
patients after oper ation had been reported by Robinneau (1933) &ud
like the oliguria which ocoured at the same time, this fall in
sodium output was thought to be due to the conservation of the ion
by the kidney as a result of diminished intake. However, many
workers among whom Moore and Ball (1952) and Renwick et al (1955)»
observed that if common salt were withdrawn from the diet, it took
several days before a low urinary sodium could be effected.
Earlier on, Wilkinson et al (1949), observed that the period of
sodium retention, oocuxing within 24 hours after operation and /
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and lasting for several days, roughly coincided with the catabolic
phase and that this retention persisted even when quantities of
sodium chloride, comparable to those given during the pre-operatlve
period, were administered orally or intravenously. All these
findings suggest that the post-operative sodium retention cannot be
explained on the basis of a reduced intake.
It must have been tempting to suggest that the post-operative
oliguria which consequently lead to a dilution of the extraoellular
fluid was in fact responsible for the diminished sodium output.
That this was not the case or that the retention of sodium and water
were two distinct phenomena became manifest when Limbert et al (1945)
and Cooper et al (1949) reported that sodium excretion was greater
in the oliguric phase than in the succeeding phase when a very dilute
urine was voided. This distinction was confirmed when Holland and
Stead (1951), undertaking to investigate the effects of pitressin
injections on the excretions of water, sodium, potassium and chloride,
reported that while there resulted a marked oliguria due to increased
tubular reabsorption, there was no demonstrable effect on the excretiaa
of sodium and other electrolytes.
The retention of a great quantity of sodium in the days
immediately following operation will cause a disturbance in osmotic
balance which in turn will result in a major rearrangement of the
body fluid and electrolyte distribution. In the light of a pot¬
assium loss - which will be discussed later - occuring during the
same period, it is conceivable that a shift of fluid and ions will
take place between the intracellular and extracellular spaces, start¬
ing as a localised reaction in the injured region and spreading to
involve other areas. Winfield et al (1951) analysing the sodium
and potassium content in the injured muscle in post-operative /
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post-operative patients observed that the sodium content was greater
and potassium content less than expeoted from the amount of oedema
fluid present. These workers suggested that as a result of altered
cell membrane permeability following injury, the retained sodium
passed into the cells liberating potassium. This concept of ionio
exchange gained confirmation from the work of MacPhee (1953) who
analysed the electrolyte content of red blood cells in patients before
and after major operation.
When it is considered that the period of increased potassium
output ceases at the end of J2 hours after operation and that sodium
retention continues for several days more, then this exchange of sod¬
ium for intracellular potassium appears to play only a minor role in
the sodium retention following operation. Le Quesne and Lewis (1953)>
cognisant of this dissociation in time between the potassium and sod¬
ium response to surgery, distinguished an early retention of sodium
and water in the first 24 hours after operation from a late sodium
retention which might coalesce with the period of early retention
or might be separated from it by a 24 hour period of negative sodium
balance. These workers pointed out that the late sodium retention
may be enhanced by potassium deficiency in view of the work of Black
and Milne (1952)* From a detailed study of their 21 patients under¬
going surgery, Le Quesne and Lewis concluded that the primary water
retention was due to the increased secretion of antidiuretic hormone
and that the periods of sodium retention were partly or wholly due




Like nitrogen, an increased urinary potassium following
operation was noted by Cuthbertson (1930) and this occurence
was thought to be a necessary accompaniment of the post-operative
nitrogen excretion in vi^w of the work of Benedict (1915) who ob¬
served that in starvation, the nitrogen loss accompanied by potass¬
ium loss was in a ratio corresponding to that of tissue protein
which is 10:1.
During the years that followed, many other workers (Howard
1946; Blixenkrone-Moller 1949; Wilkinson et al 1950) also reported
increased output of urinary potassium following surgery. But the
interesting points brought to light were that this output occu^ed
much earlier than the increased breakdown of the catabolic phase and
was maximal within the first 24 hours; that the excretion was muoh
greater than expected from the nitrogen output and that it occured
even when K intake was restricted during the 3 days following op¬
eration. Stewart (1955) further reported that the quantity lost was
variable but could amount to several grams and bore no relation to the
nitrogen output; that the lose began six hours after injury and that
its duration was much shorter than the period of sodium retention.
From all these data, he suggested that this early post-operative pot¬
assium loss was neither due to a direct conseouence of the catabolic
destruction of cellular protein nor a response of sodium retention but
a very early part of general reaction to trauma.
Working with mice Rosenthal and Tabor (1945) reported that the
potassium content in the injured hind leg was lower than that in the
uninjured counterpart and that this decrease accounted for only part
of the total amount excreted, suggesting that the difference must have
come from undamaged areas. At the same time, a gain in sodium, /
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adrenal extracts to adrenalectomleed and hypophysectoralsed rate
resulted in liver glycogen deposition and increased nitrogen ex¬
cretion due to gluooneogeneaia of tissue protein.
The role of the adrenal gland as the causative factor in
the metabolic response to surgery seemed, at this etap-e, ripe for
formal proclamation. In fact it was Albright* in 194-3, who first
proposed the causative role of the adrenal hormones to account for
the post-operative metabolic changes. This causative concept met
with further wide acceptance when it was subsequently observed that
such responses did not oocur in the absence of the adrenal glands
and that an overdose of ACTH or cortisone aoetate administration ev¬
oked raetabolio changes comparable to those following surgery.
Not long later, Ingle (1947* 1951) investigating further the
role of the adrenal gland in the production of a negative nitrogen
balanoe and sodium retention after injury, reported that in 2 s-roups
of adrenalectomised rats, one maintained on adrenal hormones and the
other on physiological saline, the former group displayed the usual
metabolic chancres after Injury but the latter group did not. These
interesting observations suggested that although the presence of ad¬
renal hormones was necessary for the changes under consideration to
take place, the increased amounts of adrenal hormones were not them¬
selves responsible for the«e changes. Ingle therefore suggested that
the role of the adrenal gland was a "permissive" one - as opposed to
causative - which aimed at maintaining homeostatsis rather than ini¬
tiating the series of events found to occur following surgery.
To test whether the "permissive role" of the adrenal gland also
operates in man, work from this laboratory (Stewart et al 1957),
Robson et al 1955» 1956, 1959{ Dudley et al 1957) has shown that
the usual metabolic responses occured following the removal of /
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of the adrenal gland in patients who, since removal of the first
had been maintained on a constant dose of cortisone. There was
the usual sodium retention, together with increased loss of pot¬
assium and nitrogen. But the increase in 17-hydroxysteroids or
formaldehydogenic steroids in urine which normally follows oper¬
ations that do not involve the adrenal cortex did not occur. The
possibility that there might be a rapid increase in aldosterone se¬
cretion during the second-stage adrenalectomy just before the removal
of the adrenal gland and therefore responsible for the metabolic
changes was suggested by Llaurado and Woodruff (1957)• This was
checked and the results showed that although there was a considerable
rise in urinary aldosterone in the first 48 hours following the first-
stage adrenalectomy, this mineralcorticoid oould hardly be detected
in the urine during a similar period after the second-stage adrenal¬
ectomy. The possibility that the metabolic changes might be init¬
iated or maintained by changes in the blood concentration of adrenal
steroids was also checked. In three subjects undergoing the second-
stage adrenalectomy but maintained on a constant intravenous infusion
of 150 mg hydrocortisone throughout the 24 hours, none of them in the
first nine hours after operation showed the 3 - to 4 - fold rise in
free steroid that occurs almost invariably after operations which do
not involve the adrenal cortex. The conclusions to be drawn from
all these investigations lend support to the belief that in human
subjects also the complex metabolic changes which follow surgical
trauma are not due primarily to the increased secretion of adreno¬
cortical steroids including aldosterone and that as Ingle had sugg¬
ested, the role of the adrenal gland is a "permissive" one since
only the presence of these steroids in concentrations above a certain
minimum appears to be necessary in order that those reactions /
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reactions which constitute the metabolic response to injury may
occur.
Purpose and Plan of Investigation.
Stewart (1961) has pointed out that although the evidence
Obtained thus far from observations on adrenalectomised patients
suggests that the initiating onuses of the response must be sought
elsewhere, nevertheless the concept of the "permissive action" of
the adrenal gland in this context becomes more convincing if it can
be proven 1) that the increased output of corticosteroids after surg¬
ery in "normal" patients represents a real increase in hormone pro¬
duction and 2) that there is neither delayed excretion or reduced
metabolic destruction of circulating hormone as a result of trauma.
It was with such a purpose in mind that this investigation
was undertaken. Production rates were measured before and after
operation to ascertain the occurence and extent of the real increase -
if any. At the same time, from the negative slopes of the diminish¬
ing specific activities (incident in the measurement of production)
together with the measurements of the urinary excretion pattern of
the administered radioactive material, it might be possible to deduce
whether in fact there was a reduced metabolic destruction or delayed
excretion as a result of operation. A total of 5 cases were investi¬
gated; four undergoing major operations not involving the removal of
the adrenal glands and one undergoing right adrenalectomy after having
previously undergone left adrenalectomy. Measurements of 17-keto-
steroids and 17 Ketogenic steroids were also carried out erery day
during the period of study; so were those of urinary potassium, sod¬
ium and total nitrogen to reflect the metabolic changes. In most
cases the period of study was three days before and three days after /
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after operation; only in one case was this period extended to 7
days after operation.
To carry out the balance studies of potassium, sodium and
total nitrogen, the patients were put on a ocnstant diet beginning
a week before the operation and extending beyond the period of study.
Their food came from the dietetic kitchen and the diet contained a
caloric ranee of 1000-2000, 0.5 NaCl, 1-2 gm K and 55-60 gm pro¬
tein. This diet was further supplemented with 4 of NaCl taken
by mouth as cachets so that a salt intake of 4.5 gm daily was main¬
tained. On the day of operation when no food was given 500 ml of
physiological saline was administered and this mode of salt admini¬
stration was continued on the days following the operation if the
patient was unable to ingest solid food. However, in four of the
/ . *
five cases investigated, the patients were well enough to begin
taking food by mouth on the day after the operation. No attempt
was made to collect faeces passed during the period of study simply
because there did not appear to be a great variation in the amounts
of the relevant substances excreted by this route. But 24 hour
urine was collected every day without preservative and stored in a
deep freeze until ready to be analysed. Stomach aspirates and bile
were also analysed whenever these were collected in the immediate
period following operation.
Results.
The results of the first three investigations carried out are
summarised on figures 21 and 22. Case 25, an elderly male patient
aged 83 underwent gastrectomy due to ? carcinoma. Hydrocortisone
production in his case was measured by the urine method and his urinary
excretion rates of the administered were 51# &nd 60$ before and /
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and after operation respectively. His pre-operative production
was found to be 15»3 mg/day and that measured one day after operation
registered a real increase to 66.6 mg/day. Case 26. a male patient
aged 66 underwent gastroenterostomy and vagotomy due to duodenal ulcer.
Measurement of hydrocortisone production in this case was oarried out
by the blood method. A pre-operative value of 26.6 mg/day was obtain¬
ed from a somewhat large miscible pool of 3*1 and a turnover with
a biological half time of 114 minutes. The post-operative product¬
ion measured one day after operation, registered an increase to 73
mg/day as obtained from a miscible pool of 4*3 ®g and a biological
half time of 59 minutes. Urinary ^^0 excretion rates were found to
be 82# and 83# of the administered dose pre- and post-operatively,
Case 27. a male patient acted 52 underwent cholecystectomy due to
obstructive jaundice. His pre-operative production as measured
by the blood method was 13.2 mg/day; this figure was calculated
from a miscible pool of 1,66 mg and a bio3.ogical half life of 122
minutes. His post-operative production showed an increase to 85.2
mg/day as calculated from a markedly increased miscible pool of
10.2 mg and a slope with a biological half life of 120 minutes.
In all the three oases, the production values one day after
operation ranged from 67 - 86 mg/day, showing that a real increase
in adrenal hormone production had taken place, Figure 21. However,
only in one case (case 26) was this real increase reflected stronmly
by the 17-ketogenic steroid patterns; but a closer examination will
reveal that 17-KGS increases did actually occur in the other two
cases (case 25, case 27), though not as pronounced from values obtain¬
ed on the 2nd and 3rd post-operative days. This real increase in
T
production could not be said to have occured from the excretion
patterns of the 17-keto3teroids. In faot, the excretion registered /
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registered by case 25 suggested a decrease in adrenal function,
that of case 26 suggested a moderate increase and that of case 27,
no change at all in adrenal function after operation.
In all thre8 cases, as judged from the balance studies
(Figure 22), it may be said that there occured a marked potassium
and nitrogen loss and an equally marked retention of sodium as a
result of operation. The potassium loss began very promptly reach¬
ing a peak during the first 24 hours but may be considered to have
reverted to normal balance by the ttffid post-operative day. Sodium
retention began very moderately but appeared to be marked on the
2nd or 3rd post-operative day. Total nitrogen loss, like potassium,
began very promptly after operation, reached a maximum on the first
or seoond post-operative day and in the case of case 27, this loss
appeared to continue beyond the 3*"d poet-operative day.
It seemed worthwhile to investigate how long the increase
in hormone production persisted as a result of operation and likewise
how long the nitrogen and electrolyte changes oontinued with partic¬
ular attention to the sodium retention. Accordingly, for this part¬
icular investigation, the period of study was extended to include
another 4 days beyond the usual 3 post-operative days; so that a
period of study of 10 days was launched, 3 days before operation and
7 days after operation. The patient, Case 28. selected for this
investigation was a male aged 60, who underwent gastrectomy due to
duodenal ulcer. His pre-cperative production was 18.0 mg/day as
calculated from a pool of O.87 mg and a biological half life of 54
minutes, Figure 23. One day after operation, he registered a prod¬
uction increase to 38.4 mg/day as calculated from an increased pool
of 2.2 mg and a biological half time of 60 minutes. The inorease
in production in this case though real, was not as marked as those /
Figure 23: Metabolic response over a longer period following surgery-
Case 28.
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those in the 3 cases previously cited. This was not surprising
since - as the physician and surgeon in charge of the case had
suggested - the operation turned out to be less serious than was
expected. Another measurement performed on the 6th post-operative
day revealed a return to normal production of 16.1 mg/day from a
pool of 0.96 mg and a biological half life of 60 minutes. This
moderate but real inorease in adrenal activity immediately following
operation was not reflected at all in the 17-ketogenic and 17-keto-
steroid excretion patterns.
Even in the face of this moderate increase in adrenal activi
there oocu^ed the usual potassium and nitrogen loss and a ooncomitar
sodium retention due to operation, Figure 83. The potassium loss
which was maximal during the 24 hour period immediately following
operation reverted to a pre-operative balance after the 3rd post¬
operative day. The sodium retention, although appeared to have
started moderately at first with a tendency to revert to a pre¬
operative balance on the 3rd day, was most marked on the 4th, 5th
and 6th post-operative days aid abruptly returif to a pre-operative
balance on the 7th day. The nitrogen loss which started immediate!
after operation was most marked on the 3rd post-operative day but
returned to a pre-operative balance two days later.
Having now established the occurrence of a real increase in
adrenal hormone production in patients undergoing operations not
involving the removal of the adrenal glands, the next obvious step
was to prove the absence of such a production in subjects undergoing
operations involving the complete removal of the adrenals. The
subject Case 29 selected for this investigation had earlier on been
confirmed to be a Cushing's case by the test and had subsequent]
had a left adrenalectomy performed on him. The removed gland /
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gland weighed some 17 Gm and showed evidence of a large diffuse
hyperplasia without evidence of mitosis. When he had recovered
from the first stage adrenalectomy, he was receiving 25 mg cortie
acetate daily until 5 days before he was due for the second-stage
adrenalectomy when he was given 200 mg cortisone acetate daily.
2 days before the operation the blood test was carried out wi
a view to measure the aotual amount of hydrocortisone the remaini
adrenal gland was producing and to repeat the test one day after
second-stage adrenalectomy to see if there was an absence of such
production. The patient was put on a diet regime just as the pr
viously mentioned patients had been so that studies of the metabo
response could also be carried out.
The results obtained from the ^^0 tests - though shocking
first because it wa3 totally unexpected - revealed some useful in
formation. A pre-operative production of I63.2 mg/day was regis
when calculated from a miscible pool of 9.8 mg and a slope with a
biological half time of 60 minutes. The one day post-operative
test registered a production of 36.0 mg/day as calculated from a
reduced miscible pool of 1.93 a^d a biological half time of 59
minutes. It is true the tests revealed a real decrease in appar
production after the removal of the remaining gland as judged froi
the sizes of the miscible pools (Fig.24); but what appeared to b
absurd were the calculated production rates of I63.2 mg/day and 3
mg/day. Evidently the measurement of the actual F production of
remaining adrenal gland pre-operatively or the measurement of an
" expected" zero production after adrenalectomy could not be achie'
even by this isotope dilution method. This is because, during t;
period of study, the 200 mg cortisone acetate which the patient w:
receiving every day underwent molecular interconversion such as :
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such as i cortisone -—* hydrocortisone.
Therefore, so long as there was an exogenous supply of hydrocortisone
in amounts larger than tracer quantities, the measurement of endogen¬
ous hydrocortisone production became impossible. Had this inter-
conversion not taken place the purpose of this particular investi¬
gation would have been completely fulfilled. As it is, because the
patient was receiving a constant dose of adrenal hormones throughout
the period of study, save only on the operation day when he was given
250 mg instead of the usual 200 mg, the only data which could be used
for comparison were the pre-operative and post-operative values of
the miscible pool. There was a real decrease of 9.8 mg to 1.9 mg
as a result of the 2nd stage adrenalectomy. This decrease could
not be attributed to a greater body utilisation poet-operatively
because the plasma specific activity slopes or the biological half
times of the two tests were very similar. It may be assumed
then, that the decrease in miscible pool was due solely to the
removal of the overactive remaining gland.
In the face of this greatly diminished or nil adrenal
activity after operation, there still occured the usual post-operative
metabolic response. The potassium and nitrogen losses together with
the sodium retention on the first and second post-operative days were
marked enough to lend support once again to the view that the role of
the adrenal gland in the metabolic response to surgery is a "permissive"
one as had originally been suggested by Ingle and subsequently found
to operate in humans from previous work undertaken in this laboratory.
Discussion.
Real increase in hormone production.
This investigation has shown conclusively that a real /
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real increase in adrenal hormone production exists as a result
of operation and that although a production with a maximum of
85 mg/day was observed to have occurred 24 hours after the operation,
it is reasonable to assume that the production between 0 and 24 hours
after the operation is greater. This assumption is based on the
fact that the highest plasma steroid levels are usually enoountered
some 12 hours after the operation and these high values will effect¬
ively increase the size of the miscible pool which in turn, together
with the nature of the slope of diminishing plasma specific activity,
will register a higher rate of hormone production. There has been
some evidence to suggest that the magnitude of the operation bears a
direct relationship with the extent of adrenal hormone production.
A post-operative production of 36 mg/day by itself indicates only
a 2o$> increase over the upper normal limit of 30 fflg/day but when
referred to a pre-operative production of 18 mg/day, the increase
becomes significant and represents a 100$ increase. The occurrence
of this real increase after operation (though moderate when compared
with values of 66-85 mg/day encountered in "more serious" operations)
was not accompanied by either elevated plasma steroid levels or ele¬
vated excretions of 17-ketogenic and 17-ketosteroids. So that, in
the light of this finding, earlier reports suggesting that no apparent
increased adrenal activity was found to occur after minor operations,
simply because there occurred no apparent change in the plasma or urine
steroid values must now be accepted with reservations.
Metabolic destruction and Excretion.
That there is a reduoed metabolic destruction of the cir¬
culating hormone in the immediate post-operative period giving rise
to raised plasma steroid levels was discussed earlier in the intro¬
ductory part of this chapter. This may be true during the /
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the period 0-24 hours after operation but from the results of
the 5 cases investigated here there was no evidence to suggest
that during the period 24 - 48 hours after operation there existed
either a reduced metabolic destruction of the circulating hormones
or a reduoed steroid e xcretion. The slopes of the lines of fit
containing the exponentially diminishing plasma steroid specifio
activities or more practically, the biological half times measured
before and after operation were very similar in 4 out of the 5 cases.
The excretion rates of the administered dose before and after oper¬
ation were also of the same order and certainly normal as evidenced
by an excretion rate of over 80$.
Production in Adrenalectomy,
It is true that the attempt to measure the activity of the
remaining adrenal gland in a patient under steroid therapy waiting
to undergo second-stage adrenalectomy had failed. Equally doomed
to failure too was the attempt to measure the "expected" zero prod¬
uction in the patient after adrenalectomy. But the attempt brought
to light the existence of an interconvertible relationship between
cortisone and hydrocortisone and as such the cause of the failure
became known. It was impossible to measure the endogenous hydro¬
cortisone production rate by the blood *4c test under these circum¬
stances. After the event it was painfully realised that the purpose
of this particular Investigation could have been fulfilled if the
urine method for the measurement of production had been used.
If this had been done, the pre-operative production value minus the
quantity of steroid administered to the patient during the last 24
hours would have revealed the production rate of the remaining
adrenal gland. And likewise, the post-operative production value /
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value minus the quantity of steroid the patient had received during
the last 24 hours would have revealed whether or not there existed
an extra-adrenal supply of hydrocortisone. Furthermore these tests
need not have to be carried out during the days immediately before
or after the operation; it may be oarried out at a time when the
patient is receiving a constant steroid dose of 25 mg/day, a period
long before and after the operation. Certainly this problem merits
further investigation and the answer one gets from using the urine
test will be not only 80 - 100$ accurate but also most rewarding.
Nitrogen. Water and Electrolyte Response.
The most notable changes which follow surgical trauma have
been the occurence of oliguria, retention of sodium and loss ofA
potassium and nitrogen. The occui-pnce of oliguria may be explained
by a decrease in glomerular filtration due to a fall in blood flow
and by an increased tubular reabsorption caused perhaps by increased
liberation of pituitary antidiuretic hormone. The increased nitroger
excretion arises from a rapid oatabolism of protein and the negative
nitrogen balance during this period cannot be prevented, although it
may be modified or minimised by suitable preparation of the patient
such as starving him or paradoxically perhaps, by protein feeding
in sufficient quantity. The duration and extent of the "catabolic
'
. v'j" '% ■
phase" which represents the body^ inherent response to trauma is
related to the nutritional state of the patient and to the gravity
of the wound. The potassium loss which occurs promptly after injury
does not persist aa long as either the increased nitrogen excretion
or the reduced sodium output and although it was alleged to be a
necessary accompaniment of the post-operative nitrogen excretion,
it was found to occur much earlier than the "catabolic phase" and /
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and the amount excreted bore no relation to the nitrogen output.
It is conceivable therefore that this early potassium loss is
neither due to the oatabolic destruction of protein nor a response
to sodium retention; that it must be of cellular origin and re¬
presents a very early part of general reaction to trauma. The
most difficult to account for of the various metabolic changes
following surgical trauma is that of sodium retention. It has been
suggested that this retention was designed to maintain fluid ton¬
icity due to the oliguria or to compensate for the early loss of
potassium; that it was due to the ionic exchange of sodium for
intracellular potassium because of increased cell permeability.
But in the light of the urinary specific gravity determinations
during the oliguria phase or of the time relationships between
the occurences of potassium loss and sodium retention, it is ev¬
ident these proposed factors appear to play only a minor role.
Other metabolic changes.
It has also been known for some time now that the serum
albumin falls abruptly after operation, so does the plasma iron
concentration. Why this happens is not certain but it is unlikely
that the former is due to a general protein depletion or the latter
to simple bleeding or external loss. There also appears to be
some disturbance of carbohydrate, fat and vitamin metabolism due
to injury. Fat is rapidly oxidised probably to provide the energy
necessary for the many altered metabolic processes and this con¬
tributes to a fall in body weight which is a characteristic feature
after injury. It is believed that carbohydrate stores are mobilised
due to the stress-induced hypeadrenalinaemla which in turn steps up
the production of ACTH and consequently the secretion of adreno¬
cortical hormones. This results in the formation of glucose /
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glucose from aminoacids arid Inhibits carbohydrate breakdown.
Associated with the "catabolic phase" there is an increased output
of riboflavin and other substances derived from vitamins of the B
complex. Has this been designed to provide the necessary co¬
enzymes for the various oxidation-reduction processes? The urinary
excretion of vitamin 0 has also been observed to fall after injury.
Is this change intended to facilitate healing of the wound since
it is known that deficiency of this vitamin gives rise to poor prog¬
nosis? Whether the fall in excretion of ascorbic acid after injury
is due to an increased retention by the tissue or to a greatly in¬
creased oxidative breakdown is still uncertain. What is certain is
that these metabolic changes just discussed do merit further invest¬
igations.
Mechanism Responsible for the Metabolic Changes.
For some time now the mechanisms by which these metabolic
changes are initiated and sustained have received considerable
attention. Trauma, be it due to surgery or accident, evokes a
real increase in adrenocortical secretion; this gives rise to ele¬
vated plasma steroid levels and to increased urinary steroid ex¬
cretion. There is also an increased liberation of aldosterone
and of antidiuretic hormone. Albright's proposal that these
increased hormone secretions are solely responsible for the post¬
surgical metabolic changes is now unacceptable because it has been
shown that patients kept on a constant supply of hormone and sub¬
jected to adrenalectomy and hypophysectomy displayed the usual
metabolic changes after operation. However, as had already been
mentioned the "permissive action" of the adrenal gland implies that
the initiating causes of the response must be sought elsewhere and /
and it has been suggested that a closer examination of the sequenci
of events following cell damage - which gives rise to changes in
the distribution of water and electrolytes and possibly the lib¬
eration of toxic substances thus causing further metabolic changes
may reveal some satisfactory explanation for the various metabolic




1. Two methods were used for the measurement of the
endogenous hydrocortisone production rate in Man. The blood
method largely followed that proposed by Peterson and Wyngaarden
(1956) and the urine method, to a great extent, that proposed
by Cope and Black (1958) - A dose of 10 - 20 jug hydrocortisone
containing 0.2 juc of radioactivity was administered to the subject
under investigation and from the measurement of the rate of dilution
the administered hydrocortisone underwent with the hydrocortisone
produced by the subjects own adrenals, the endogenous hydrocortison*
production was calculated. All radioactivity counting was carried
out using a Panax Liquid Scintillation Counter which recorded a
counting efficiency of 70$ and a toluene base liquid phosphor.
There appeared to be good agreement in the results obtained by the
two methods. But while agreeing that a dose of 0.2 juc wue quite
sufficient for the measurement of production from 24 hour urine,
the amount of radioactivity present in the plasma, 0 - 2\ hours after
administration of the dose, was too small for accurate measurement
and experience suggests that a dose of 1 - 1.5 ;uc instead of 0.2 >ic
will not only considerably facilitate measurement of production by
the blood method but also render it more reliable.
2. After the establishment of the "normal" production rate
patterns, application was made to the investigation of 13 cases of
Cushin^s syndrome, 4 cases of Hypoadrenalism and 7 cases of Hirsut¬
ism. From five patients with no apparent endocrine abnormality
(three convalescent and two pre-surgical cases) a normal production
range of 16 - 30 mg/day was obtained by the blood technique and
from a series of seven healthy young adults a production of 9 - 19
mg/day was obtained by the urine technique. Eight of the /
zzc
the thirteen Clashing'8 cases registered an elevated hydrocortisone
production and when compared with the 17-KGS and 17-KS values obtaii
ed at the same time, the production values have much to recommend
the 14c test as the method of choice for assessing adrenal function
especially in this clinical condition where the changes are often
■ so moderate that they may not be reflected in the 17-KGS and 17-KS
excretion values. Two low and two normal production values were
observed in the four hypoadrenal cases investigated but the corrcsp<
ing low or normal values of 17-KGS and 17-KS excretions obtained in
these cases suggest that in hypoadrenal states these routine labor¬
atory tests are reliable enough to refleot the decreased state of
adrenal activity. A normal production was observed to occur in
six of the seven Hirsute cases investigated when measured by the
urine method. But measurements carried out by the blood method
revealed values which, although agreed well with those obtained
from urine studies, surprisingly indicated a sub-normal production
when judged by a normal production of 16 - 30 mg/day. In the
absence of a normal production range obtained from healthy women
of comparable age group it has not been possible to assert whether
in fact these blood production values are normal or indeed sub-norme
3. A real post-operative increase in hydrocortisone product¬
ion was found to occur in 4 patients undergoing surgery which did
not involve the removal of the adrenal glands. At the same time th
usual nitrogen, water and electrolyte changes which have been obser»
f
to follow injury also occured in these patients when balance studies
were carried out before and after operation. These investigations
were carried out with a view to obtaining further information regard
ing the role of the adrenal gland in the metabolic response to /
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to surgery. An attempt to measure the pre- and post-operative
hormone production in a patient undergoing a second-stage adrenal¬
ectomy was also made. The attempt failed in the fulfillment of
its purpose because the constant but large dose of cortisone acetate
which the patient was receiving during the immediate period before
and after operation underwent an interconvertible relationship with
hydrocortisone and as such it became impossible to measure the endo¬
genous hydrocortisone production either before or after the secor.d-
stagre adrenalectomy. However, a greatly diminished hydrocortisone
pool was observed after the operation and in the faoe of a potassium
and nitrogen loss with a concomitant sodium retention occuring dur¬
ing the same period, the role of the adrenal gland as "permissive"
of these metabolic responses after surgery became once again very
suggestive.
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